Positive	O
and	O
negative	O
roles	O
of	O
the	O
trans-acting	B-protein
T	I-protein
cell	I-protein
factor-1	I-protein
for	O
the	O
acquisition	O
of	O
distinct	O
Ly-49	B-protein
MHC	I-protein
class	I-protein
I	I-protein
receptors	I-protein
by	O
NK	B-cell_type
cells	I-cell_type
.	O

Members	O
of	O
the	O
Ly-49	B-DNA
gene	I-DNA
family	I-DNA
code	O
for	O
class	B-protein
I	I-protein
MHC-specific	I-protein
receptors	I-protein
that	O
regulate	O
NK	O
cell	O
function	O
.	O

Due	O
to	O
a	O
combinatorial	O
distribution	O
of	O
Ly-49	B-protein
receptors	I-protein
,	O
NK	B-cell_type
cells	I-cell_type
display	O
considerable	O
clonal	O
heterogeneity	O
.	O

The	O
acquisition	O
of	O
one	O
Ly-49	B-protein
receptor	I-protein
,	O
Ly-49A	B-protein
is	O
strictly	O
dependent	O
on	O
the	O
transcriptional	B-protein
trans-acting	I-protein
factor	I-protein
T	B-protein
cell-specific	I-protein
factor-1	I-protein
(	O
TCF-1	B-protein
)	O
.	O

Indeed	O
,	O
TCF-1	B-protein
binds	O
to	O
two	O
sites	O
in	O
the	O
Ly-49a	B-DNA
promoter	I-DNA
and	O
regulates	O
its	O
activity	O
,	O
suggesting	O
that	O
the	O
Ly-49a	B-DNA
gene	I-DNA
is	O
a	O
direct	O
TCF-1	B-protein
target	O
.	O

TCF-1	B-protein
deficiency	O
resulted	O
in	O
the	O
altered	O
usage	O
of	O
additional	O
Ly-49	B-protein
receptors	I-protein
.	O

We	O
show	O
in	O
this	O
study	O
,	O
using	O
TCF-1	B-protein
beta	I-protein
(	I-protein
2	I-protein
)	I-protein
-microglobulin	I-protein
double-deficient	O
mice	O
,	O
that	O
these	O
repertoire	O
alterations	O
are	O
not	O
due	O
to	O
Ly-49/MHC	O
class	O
I	O
interactions	O
.	O

Our	O
findings	O
rather	O
suggest	O
a	O
TCF-1	B-protein
-dependent	O
,	O
cell	O
autonomous	O
effect	O
on	O
the	O
acquisition	O
of	O
multiple	O
Ly-49	B-protein
receptors	I-protein
.	O

Besides	O
reduced	O
receptor	O
usage	O
(	O
Ly-49A	B-protein
and	I-protein
D	I-protein
)	O
,	O
we	O
also	O
observed	O
no	O
effect	O
(	O
Ly-49C	B-protein
)	O
and	O
significantly	O
expanded	O
(	O
Ly-49G	B-protein
and	I-protein
I	I-protein
)	O
receptor	O
usage	O
in	O
the	O
absence	O
of	O
TCF-1	B-protein
.	O

These	O
effects	O
did	O
not	O
in	O
all	O
cases	O
correlate	O
with	O
the	O
presence	O
of	O
TCF	B-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
respective	O
proximal	B-DNA
promoter	I-DNA
.	O

Therefore	O
,	O
besides	O
TCF-1	B-protein
binding	O
to	O
the	O
proximal	B-DNA
promoter	I-DNA
,	O
Ly-49	O
acquisition	O
may	O
also	O
be	O
regulated	O
by	O
TCF-1	B-protein
binding	O
to	O
more	O
distant	O
cis-acting	B-DNA
elements	I-DNA
and/or	O
by	O
regulating	O
the	O
expression	O
of	O
additional	O
trans-acting	B-DNA
factors	I-DNA
.	O

Consistent	O
with	O
the	O
observed	O
differential	O
,	O
positive	O
or	O
negative	O
role	O
of	O
TCF-1	B-protein
for	O
Ly-49	B-protein
receptor	I-protein
acquisition	O
,	O
reporter	O
gene	O
assays	O
revealed	O
the	O
presence	O
of	O
an	O
inducing	O
as	O
well	O
as	O
a	O
repressing	O
TCF	B-DNA
site	I-DNA
in	O
certain	O
proximal	O
Ly-49	B-DNA
promoters	I-DNA
.	O

These	O
findings	O
reveal	O
an	O
important	O
role	O
of	O
TCF-1	B-protein
for	O
the	O
formation	O
of	O
the	O
NK	B-protein
cell	I-protein
receptor	I-protein
repertoire	O
.	O

l	NULL
51—3	NULL
``	NULL
3	NULL
2	NULL
``	NULL
a	NULL
=/	NULL
_	NULL
The	NULL
Attune	NULL
``	NULL
NxT	NULL
Flow	NULL
Cytometer	NULL
system	NULL
jt	NULL
|	NULL
mae	NULL
-_	NULL
Let	NULL
's	NULL
get	NULL
to	NULL
the	NULL
science	NULL
e	NULL
Positive	NULL
and	NULL
Negative	NULL
Roles	NULL
of	NULL
the	NULL
Trans	NULL
;	NULL
-Acting	NULL
T	NULL
Cell	NULL
Factor-1	NULL
for	NULL
the	NULL
Acquisition	NULL
of	NULL
ImmunOIOgy	NULL
Distinct	NULL
Ly-49	NULL
MHC	NULL
Class	NULL
I	NULL
Receptors	NULL
by	NULL
NK	NULL
Cells	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Béatrice	NULL
Kunz	NULL
and	NULL
Werner	NULL
Held	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:6181-6187	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.10.6181	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/10/6181	NULL
AP	NULL
“	NULL
meJournal	NULL
o	NULL
dge	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
45	NULL
articles	NULL
,	NULL
17	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/10/6181	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Positive	NULL
and	NULL
Negative	NULL
Roles	NULL
of	NULL
the	NULL
Trans-Acting	NULL
T	NULL
Cell	NULL
Factor-1	NULL
for	NULL
the	NULL
Acquisition	NULL
of	NULL
Distinct	NULL
Ly-49	NULL
MHC	NULL
Class	NULL
I	NULL
Receptors	NULL
by	NULL
NK	NULL
Cells	NULL
!	NULL

Béatrice	NULL
Kunz	NULL
and	NULL
Werner	NULL
Held*	NULL
Members	NULL
of	NULL
the	NULL
Ly-49	NULL
gene	NULL
family	NULL
code	NULL
for	NULL
class	NULL
I	NULL
MHC-specific	NULL
receptors	NULL
that	NULL
regulate	NULL
NK	NULL
cell	NULL
function	NULL
.	NULL

Due	NULL
to	NULL
a	NULL
combinatorial	NULL
distribution	NULL
of	NULL
Ly-49	NULL
receptors	NULL
,	NULL
NK	NULL
cells	NULL
display	NULL
considerable	NULL
clonal	NULL
heterogeneity	NULL
.	NULL

The	NULL
acquisition	NULL
of	NULL
one	NULL
Ly-49	NULL
receptor	NULL
,	NULL
Ly-49A	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
the	NULL
transcriptional	NULL
trans-acting	NULL
factor	NULL
T	NULL
cell-specific	NULL
factor-1	NULL
(	NULL
TCF-1	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
TCF-1	NULL
binds	NULL
to	NULL
two	NULL
sites	NULL
in	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
and	NULL
regulates	NULL
its	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
Ly-49a	NULL
gene	NULL
is	NULL
a	NULL
direct	NULL
TCF-1	NULL
target	NULL
.	NULL

TCF-1	NULL
deficiency	NULL
resulted	NULL
in	NULL
the	NULL
altered	NULL
usage	NULL
of	NULL
additional	NULL
Ly-49	NULL
receptors	NULL
.	NULL

We	NULL
show	NULL
in	NULL
this	NULL
study	NULL
,	NULL
using	NULL
TCF-1	NULL
B	NULL
;	NULL
,	NULL
-microglobulin	NULL
double-deficient	NULL
mice	NULL
,	NULL
that	NULL
these	NULL
repertoire	NULL
alterations	NULL
are	NULL
not	NULL
due	NULL
to	NULL
Ly-49/MHC	NULL
class	NULL
I	NULL
interactions	NULL
.	NULL

Our	NULL
findings	NULL
rather	NULL
suggest	NULL
a	NULL
TCF-1-dependent	NULL
,	NULL
cell	NULL
autonomous	NULL
effect	NULL
on	NULL
the	NULL
acquisition	NULL
of	NULL
multiple	NULL
Ly-49	NULL
receptors	NULL
.	NULL

Besides	NULL
reduced	NULL
receptor	NULL
usage	NULL
(	NULL
Ly-49A	NULL
and	NULL
D	NULL
)	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
no	NULL
effect	NULL
(	NULL
Ly-49C	NULL
)	NULL
and	NULL
significantly	NULL
expanded	NULL
(	NULL
Ly-49G	NULL
and	NULL
I	NULL
)	NULL
receptor	NULL
usage	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
.	NULL

These	NULL
effects	NULL
did	NULL
not	NULL
in	NULL
all	NULL
cases	NULL
correlate	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
TCF	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
respective	NULL
proximal	NULL
promoter	NULL
.	NULL

Therefore	NULL
,	NULL
besides	NULL
TCF-1	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
promoter	NULL
,	NULL
Ly-49	NULL
acquisition	NULL
may	NULL
also	NULL
be	NULL
regulated	NULL
by	NULL
TCF-1	NULL
binding	NULL
to	NULL
more	NULL
distant	NULL
cis-acting	NULL
elements	NULL
and/or	NULL
by	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
additional	NULL
trans-acting	NULL
factors	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
observed	NULL
differential	NULL
,	NULL
positive	NULL
or	NULL
negative	NULL
role	NULL
of	NULL
TCF-1	NULL
for	NULL
Ly-49	NULL
receptor	NULL
acquisition	NULL
,	NULL
reporter	NULL
gene	NULL
assays	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
inducing	NULL
as	NULL
well	NULL
as	NULL
a	NULL
repressing	NULL
TCF	NULL
site	NULL
in	NULL
certain	NULL
proximal	NULL
Ly-49	NULL
promoters	NULL
.	NULL

These	NULL
findings	NULL
reveal	NULL
an	NULL
important	NULL
role	NULL
of	NULL
TCF-1	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NK	NULL
cell	NULL
receptor	NULL
repertoire	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
6181-6187.	NULL
with	NULL
their	NULL
cognate	NULL
ligands	NULL
on	NULL
target	NULL
cells	NULL
.	NULL

This	NULL
receptor	NULL
fam-	NULL
ily	NULL
includes	NULL
both	NULL
activating	NULL
and	NULL
inhibitory	NULL
receptors	NULL
that	NULL
are	NULL
specific	NULL
for	NULL
classical	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
inhibitory	NULL
receptors	NULL
prevents	NULL
NK	NULL
cells	NULL
from	NULL
attacking	NULL
normal	NULL
cells	NULL
and	NULL
enables	NULL
them	NULL
to	NULL
detect	NULL
autologous	NULL
MHC	NULL
class	NULL
I	NULL
loss	NULL
variants	NULL
.	NULL

These	NULL
receptors	NULL
are	NULL
thus	NULL
important	NULL
to	NULL
maintain	NULL
NK	NULL
cell	NULL
tolerance	NULL
toward	NULL
normal	NULL
cells	NULL
and	NULL
to	NULL
ensure	NULL
reactivity	NULL
toward	NULL
aberrant	NULL
cells	NULL
.	NULL

The	NULL
role	NULL
of	NULL
activating	NULL
Ly-49	NULL
receptors	NULL
is	NULL
less	NULL
well	NULL
known	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
Ly-49	NULL
receptor	NULL
family	NULL
are	NULL
highly	NULL
homologous	NULL
(	NULL
59-91	NULL
%	NULL
)	NULL
,	NULL
except	NULL
Ly-49B	NULL
,	NULL
which	NULL
is	NULL
more	NULL
distantly	NULL
related	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Six	NULL
family	NULL
members	NULL
were	NULL
shown	NULL
to	NULL
recognize	NULL
classical	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
using	NULL
functional	NULL
and/or	NULL
cell-cell	NULL
adhesion	NULL
assays	NULL
.	NULL

Although	NULL
some	NULL
Ly-49	NULL
receptors	NULL
exhibit	NULL
rather	NULL
broad	NULL
MHC	NULL
class	NULL
I	NULL
cross-reactivity	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Ly-49A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
1	NULL
)	NULL
,	NULL
others	NULL
(	NULL
Ly-49E	NULL
,	NULL
F	NULL
,	NULL
and	NULL
G2	NULL
)	NULL
bind	NULL
selectively	NULL
to	NULL
certain	NULL
MHC	NULL
class	NULL
I	NULL
alleles	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Inhibitory	NULL
Ly-49	NULL
receptors	NULL
contain	NULL
immunoreceptor	NULL
tyrosine-based	NULL
inhibitory	NULL
motifs	NULL
in	NULL
their	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
which	NULL
are	NULL
required	NULL
to	NULL
trans-duce	NULL
the	NULL
inhibitory	NULL
signal	NULL
.	NULL

Two	NULL
family	NULL
members	NULL
(	NULL
Ly-49D	NULL
and	NULL
H	NULL
)	NULL
lack	NULL
this	NULL
motif	NULL
.	NULL

Upon	NULL
engagement	NULL
of	NULL
MHC	NULL
ligand	NULL
and/or	NULL
receptor	NULL
cross-linking	NULL
using	NULL
mAbs	NULL
,	NULL
these	NULL
receptors	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
NK	NULL
cells	NULL
via	NULL
associated	NULL
DAP-12	NULL
adaptor	NULL
molecules	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

I	NULL
y-49	NULL
receptors	NULL
regulate	NULL
NK	NULL
cell	NULL
function	NULL
upon	NULL
interaction	NULL
Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Lausanne	NULL
Branch	NULL
,	NULL
University	NULL
of	NULL
Lausanne	NULL
,	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
14	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
12	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
W.H	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
START	NULL
fellowship	NULL
and	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Swiss	NULL
National	NULL
Science	NULL
Foundation	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Werner	NULL
Held	NULL
,	NULL
Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
155	NULL
Ch	NULL
.	NULL

des	NULL
Boveresses	NULL
,	NULL
1066	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
wheld	NULL
@	NULL
isrec.unil.ch	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
genes	NULL
encoding	NULL
Ly-49	NULL
family	NULL
receptors	NULL
are	NULL
tightly	NULL
clustered	NULL
in	NULL
the	NULL
NK	NULL
complex	NULL
on	NULL
mouse	NULL
chromosome	NULL
6	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
10	NULL
Ly-49	NULL
genes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
complete	NULL
mRNAs	NULL
in	NULL
C57BL/6	NULL
mice	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Ly-49	NULL
receptors	NULL
is	NULL
restricted	NULL
to	NULL
NK	NULL
cells	NULL
,	NULL
NK	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
occasional	NULL
conventional	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
other	NULL
multigene	NULL
families	NULL
,	NULL
like	NULL
MHC	NULL
class	NULL
I	NULL
or	NULL
II	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Ly-49	NULL
genes	NULL
is	NULL
not	NULL
coregulated	NULL
.	NULL

Individual	NULL
Ly-49	NULL
receptors	NULL
are	NULL
expressed	NULL
by	NULL
partially	NULL
overlapping	NULL
subpopulations	NULL
of	NULL
10-50	NULL
%	NULL
of	NULL
peripheral	NULL
NK	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Ly-49B	NULL
and	NULL
Ly-49E	NULL
receptors	NULL
are	NULL
expressed	NULL
only	NULL
by	NULL
occasional	NULL
(	NULL
<	NULL
2	NULL
%	NULL
)	NULL
NK	NULL
cells	NULL
based	NULL
on	NULL
single	NULL
cell	NULL
RT-PCR	NULL
analysis	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
NK	NULL
cells	NULL
display	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
available	NULL
Ly-49	NULL
receptors	NULL
(	NULL
10	NULL
)	NULL
,	NULL
whereby	NULL
receptor	NULL
expression	NULL
usually	NULL
occurs	NULL
from	NULL
a	NULL
single	NULL
allele	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
coexpression	NULL
of	NULL
inhibitory	NULL
Ly-49	NULL
receptors	NULL
is	NULL
detected	NULL
at	NULL
frequencies	NULL
that	NULL
are	NULL
expected	NULL
when	NULL
the	NULL
receptors	NULL
are	NULL
expressed	NULL
independently	NULL
and	NULL
coexpression	NULL
coincides	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

Ly-49	NULL
receptors	NULL
are	NULL
acquired	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
,	NULL
and	NULL
the	NULL
bone	NULL
marrow	NULL
environment	NULL
seems	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
inducing	NULL
Ly-49	NULL
receptor	NULL
expression	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

During	NULL
development	NULL
,	NULL
Ly-49	NULL
receptors	NULL
are	NULL
acquired	NULL
in	NULL
an	NULL
ordered	NULL
fashion	NULL
,	NULL
one	NULL
Ly-49	NULL
receptor	NULL
at	NULL
a	NULL
time	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

At	NULL
each	NULL
stage	NULL
,	NULL
NK	NULL
cells	NULL
acquire	NULL
a	NULL
particular	NULL
receptor	NULL
in	NULL
an	NULL
all	NULL
or	NULL
none	NULL
fashion	NULL
.	NULL

Once	NULL
acquired	NULL
,	NULL
the	NULL
patterns	NULL
of	NULL
Ly-49	NULL
expression	NULL
in	NULL
NK	NULL
cells	NULL
are	NULL
stably	NULL
maintained	NULL
also	NULL
through	NULL
cell	NULL
division	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
extinction	NULL
of	NULL
Ly-49	NULL
expression	NULL
seems	NULL
to	NULL
occur	NULL
in	NULL
NK	NULL
T	NULL
cells	NULL
to	NULL
allow	NULL
their	NULL
maturation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
insights	NULL
into	NULL
the	NULL
process	NULL
of	NULL
Ly-49	NULL
receptor	NULL
distribu-tion	NULL
,	NULL
we	NULL
have	NULL
begun	NULL
to	NULL
investigate	NULL
the	NULL
control	NULL
over	NULL
Ly-49	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
contains	NULL
two	NULL
sites	NULL
for	NULL
transcriptional	NULL
trans-acting	NULL
factors	NULL
such	NULL
as	NULL
T	NULL
cell	NULL
factor-1	NULL
(	NULL
TCF-1	NULL
)	NULL
,	NULL
``	NULL
denoted	NULL
TCF	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
.	NULL

rTCF-1	NULL
binds	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
TCF	NULL
,	NULL
T	NULL
cell	NULL
factor	NULL
;	NULL
Bm	NULL
,	NULL
GFP	NULL
,	NULL
green	NULL
fluorescent	NULL
protein	NULL
;	NULL
LEF	NULL
,	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
;	NULL
5	NULL
``	NULL
-RACE	NULL
,	NULL
5'-rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
end	NULL
;	NULL
tsp	NULL
,	NULL
transcriptional	NULL
start	NULL
point	NULL
.	NULL

0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6182	NULL
these	NULL
sites	NULL
in	NULL
EMSAs	NULL
,	NULL
and	NULL
TCF-1	NULL
binding	NULL
regulates	NULL
Ly-49a	NULL
promoter	NULL
activity	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
acquisition	NULL
of	NULL
the	NULL
Ly-49A	NULL
receptor	NULL
in	NULL
vivo	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
TCE-1	NULL
based	NULL
on	NULL
the	NULL
analysis	NULL
of	NULL
TCF-1-deficient	NULL
mice	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
TCF-1	NULL
binding	NULL
to	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
is	NULL
a	NULL
critical	NULL
event	NULL
for	NULL
Ly-49A	NULL
acquisition	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL

TCF-1	NULL
was	NULL
discovered	NULL
based	NULL
on	NULL
its	NULL
binding	NULL
to	NULL
certain	NULL
lympho-cyte-specific	NULL
enhancers	NULL
.	NULL

Although	NULL
TCF-1	NULL
and	NULL
related	NULL
factors	NULL
of	NULL
the	NULL
TCF	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
(	NULL
LEF	NULL
)	NULL
family	NULL
(	NULL
which	NULL
includes	NULL
TCF-1	NULL
,	NULL
-3	NULL
,	NULL
-4	NULL
,	NULL
and	NULL
LEF-1	NULL
in	NULL
mammals	NULL
)	NULL
have	NULL
no	NULL
transactivation	NULL
capacity	NULL
on	NULL
binding	NULL
site	NULL
multimers	NULL
,	NULL
they	NULL
acquire	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
upon	NULL
the	NULL
association	NULL
with	NULL
B-catenin	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

TCF/B-catenin	NULL
complexes	NULL
are	NULL
formed	NULL
transiently	NULL
in	NULL
response	NULL
to	NULL
wingless/wint	NULL
signaling	NULL
and	NULL
mediate	NULL
the	NULL
expression	NULL
of	NULL
TCF-depen-dent	NULL
target	NULL
genes	NULL
(	NULL
23-26	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
B-catenin	NULL
,	NULL
TCFs	NULL
act	NULL
as	NULL
transcriptional	NULL
repressors	NULL
due	NULL
to	NULL
their	NULL
association	NULL
with	NULL
Groucho-related	NULL
proteins	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
constitutively	NULL
expressed	NULL
,	NULL
TCF-1	NULL
(	NULL
and	NULL
its	NULL
homologue	NULL
LEF-1	NULL
)	NULL
plays	NULL
an	NULL
architectural	NULL
role	NULL
independent	NULL
of	NULL
B-catenin	NULL
binding	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
minimal	NULL
TCRa	NULL
enhancer	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
TCP/LEF-induced	NULL
,	NULL
context-dependent	NULL
assembly	NULL
of	NULL
a	NULL
higher	NULL
order	NULL
nucleo-protein	NULL
complex	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Ly-49a	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
regulated	NULL
by	NULL
TCF-1	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
B-catenin	NULL
binding	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Ly-49A	NULL
usage	NULL
,	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Ly-49	NULL
receptor	NULL
family	NULL
were	NULL
not	NULL
stringently	NULL
dependent	NULL
on	NULL
TCF-1	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Nev-ertheless	NULL
,	NULL
the	NULL
sizes	NULL
of	NULL
most	NULL
Ly-49-defined	NULL
NK	NULL
cell	NULL
subsets	NULL
were	NULL
altered	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
assessed	NULL
the	NULL
Ly-49	NULL
receptor	NULL
repertoire	NULL
in	NULL
TCF-1/B	NULL
,	NULL
-microglobulin	NULL
(	NULL
B	NULL
,	NULL
m	NULL
)	NULL
double-deficient	NULL
mice	NULL
to	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
alterations	NULL
are	NULL
due	NULL
to	NULL
Ly-49/MHC	NULL
class	NULL
I	NULL
interaction	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
TCF-1	NULL
positively	NULL
regulates	NULL
the	NULL
acquisition	NULL
of	NULL
Ly-49A	NULL
and	NULL
D	NULL
,	NULL
and	NULL
depresses	NULL
Ly-49G	NULL
and	NULL
I	NULL
,	NULL
while	NULL
Ly-49C	NULL
is	NULL
not	NULL
affected	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
a	NULL
dual	NULL
role	NULL
for	NULL
TCF-1	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NK	NULL
cell	NULL
receptor	NULL
repertoire	NULL
.	NULL

They	NULL
are	NULL
discussed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
respective	NULL
Ly-49	NULL
genes	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Mice	NULL
C57BL/6	NULL
(	NULL
B6	NULL
)	NULL
(	NULL
H-2	NULL
``	NULL
)	NULL
and	NULL
B10.D2	NULL
(	NULL
H-2	NULL
``	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Harlan	NULL
Olac	NULL
(	NULL
Horst	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
.	NULL

B	NULL
,	NULL
m-deficient	NULL
B6	NULL
mice	NULL
were	NULL
obtained	NULL
from	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
(	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

TCF-1	NULL
exon	NULL
VII	NULL
knockout	NULL
and	NULL
Ly-49A	NULL
transgenic	NULL
mice	NULL
have	NULL
been	NULL
described	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

All	NULL
mice	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
homozygous	NULL
for	NULL
a	NULL
B6-derived	NULL
NK	NULL
gene	NULL
complex	NULL
.	NULL

This	NULL
was	NULL
initially	NULL
ascertained	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
to	NULL
detect	NULL
an	NULL
RFLP	NULL
in	NULL
the	NULL
Ly-49a	NULL
gene	NULL
between	NULL
129Sv	NULL
and	NULL
B6	NULL
mouse	NULL
strains	NULL
(	NULL
EcoRI-digested	NULL
genomic	NULL
DNA	NULL
hybridized	NULL
with	NULL
a	NULL
Ly-494	NULL
cDNA	NULL
probe	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
B6	NULL
origin	NULL
of	NULL
receptors	NULL
encoded	NULL
in	NULL
the	NULL
NK	NULL
gene	NULL
complex	NULL
was	NULL
ascertained	NULL
using	NULL
flow	NULL
cytometry	NULL
with	NULL
B6	NULL
allele-specific	NULL
mAbs	NULL
Al	NULL
(	NULL
Ly-49A	NULL
)	NULL
and	NULL
PK136	NULL
(	NULL
NK1.1	NULL
)	NULL
.	NULL

TCF-1-deficient	NULL
B	NULL
,	NULL
m-deficient	NULL
,	NULL
H-2	NULL
``	NULL
``	NULL
or	NULL
Ly-49A	NULL
transgenic	NULL
mice	NULL
were	NULL
obtained	NULL
by	NULL
back-crossing	NULL
to	NULL
the	NULL
respective	NULL
strains	NULL
and	NULL
intercrossing	NULL
.	NULL

Appropriate	NULL
offspring	NULL
was	NULL
identified	NULL
using	NULL
flow	NULL
cytometry	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
H-2D	NULL
``	NULL
(	NULL
KH-95	NULL
)	NULL
,	NULL
H-2D	NULL
%	NULL
(	NULL
34.2.12	NULL
)	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
or	NULL
Ly-49A	NULL
(	NULL
JR9-318	NULL
)	NULL
.	NULL

Experimental	NULL
mice	NULL
were	NULL
8-12	NULL
wk	NULL
old	NULL
.	NULL

Flow	NULL
cytometry	NULL
Spleen	NULL
cell	NULL
suspensions	NULL
were	NULL
passed	NULL
over	NULL
nylon	NULL
wool	NULL
columns	NULL
.	NULL

One	NULL
million	NULL
nonadherent	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
24G2	NULL
(	NULL
anti-CD16/32	NULL
)	NULL
hybridoma	NULL
supernatant	NULL
to	NULL
reduce	NULL
background	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
NK1.1	NULL
PE	NULL
and	NULL
CD3	NULL
cychrome	NULL
plus	NULL
appropriate	NULL
combinations	NULL
of	NULL
FITC-	NULL
or	NULL
biotin-labeled	NULL
anti-Ly-49	NULL
mAbs	NULL
:	NULL
SW5E6	NULL
(	NULL
Ly-49C/D	NULL
;	NULL
4D11	NULL
(	NULL
Ly-49G	NULL
)	NULL
,	NULL
4E5	NULL
(	NULL
Ly-49D	NULL
)	NULL
(	NULL
all	NULL
from	NULL
PharMingen	NULL
)	NULL
,	NULL
JR9-318	NULL
(	NULL
Ly-49A	NULL
)	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
4L03911	NULL
(	NULL
Ly-49C	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

EL-4	NULL
T	NULL
cell	NULL
lymphoma	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
FITC-la-beled	NULL
Ly-49	NULL
mAbs	NULL
(	NULL
listed	NULL
above	NULL
)	NULL
and	NULL
propidium	NULL
iodide	NULL
to	NULL
exclude	NULL
dead	NULL
cells	NULL
.	NULL

In	NULL
general	NULL
,	NULL
5	NULL
X	NULL
10	NULL
%	NULL
live	NULL
cells	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
FACSCalibur	NULL
using	NULL
CellQuest	NULL
software	NULL
for	NULL
data	NULL
evaluation	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

TCF-1	NULL
DEPENDENCE	NULL
OF	NULL
THE	NULL
Ly-49	NULL
RECEPTOR	NULL
REPERTOIRE	NULL
Cloning	NULL
of	NULL
5°	NULL
Ly-49	NULL
sequence	NULL
Genomic	NULL
DNA	NULL
sequence	NULL
upstream	NULL
of	NULL
known	NULL
Ly-49	NULL
cDNA	NULL
sequences	NULL
was	NULL
isolated	NULL
by	NULL
PCR	NULL
using	NULL
sense	NULL
primers	NULL
that	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
published	NULL
Ly-49a	NULL
upstream	NULL
sequence	NULL
.	NULL

Numbers	NULL
indicate	NULL
the	NULL
position	NULL
relative	NULL
to	NULL
the	NULL
Ly-49a	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
35	NULL
)	NULL
:	NULL
Ly-49a	NULL
(	NULL
-362	NULL
)	NULL
,	NULL
the	NULL
Xbal	NULL
site	NULL
is	NULL
un-derlined	NULL
:	NULL
sense	NULL
,	NULL
5'-AAAA	NULL
TCTAgA	NULL
AAA	NULL
ATg	NULL
TAA	NULL
Agg	NULL
AAg	NULL
ACT	NULL
TCA	NULL
CC	NULL
.	NULL

A	NULL
second	NULL
sense	NULL
primer	NULL
at	NULL
the	NULL
Psfl	NULL
site	NULL
of	NULL
Ly-49a	NULL
is	NULL
indicated	NULL
in	NULL
boldface	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

These	NULL
two	NULL
primers	NULL
were	NULL
used	NULL
individually	NULL
in	NULL
conjunction	NULL
with	NULL
gene-specific	NULL
antisense	NULL
primers	NULL
specific	NULL
for	NULL
-untranslated	NULL
regions	NULL
of	NULL
different	NULL
Ly-49	NULL
cDNAs	NULL
.	NULL

The	NULL
sequence	NULL
complementary	NULL
to	NULL
the	NULL
primers	NULL
is	NULL
indicated	NULL
in	NULL
boldface	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
Ly-49a	NULL
fragment	NULL
was	NULL
derived	NULL
from	NULL
clone	NULL
9-1	NULL
(	NULL
35	NULL
)	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
30	NULL
pul	NULL
using	NULL
100	NULL
ng	NULL
of	NULL
B6-derived	NULL
tail	NULL
DNA	NULL
,	NULL
300	NULL
nM	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
and	NULL
1.5	NULL
U	NULL
of	NULL
AmpliTaq	NULL
in	NULL
1	NULL
%	NULL
buffer	NULL
supplied	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Roche	NULL
Diagnostics	NULL
,	NULL
Rotkreuz	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Conditions	NULL
for	NULL
PCR	NULL
were	NULL
5	NULL
min	NULL
at	NULL
92°C	NULL
,	NULL
then	NULL
40	NULL
cycles	NULL
of	NULL
1	NULL
min	NULL
at	NULL
92°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
55°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
72°C	NULL
,	NULL
and	NULL
finally	NULL
5	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

Amplification	NULL
products	NULL
were	NULL
gel	NULL
purified	NULL
and	NULL
cloned	NULL
using	NULL
the	NULL
TA	NULL
cloning	NULL
kit	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
PCR	NULL
and	NULL
sequencing	NULL
errors	NULL
,	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
clones	NULL
were	NULL
completely	NULL
sequenced	NULL
on	NULL
both	NULL
strands	NULL
.	NULL

The	NULL
antisense	NULL
PCR	NULL
primers	NULL
were	NULL
chosen	NULL
to	NULL
yield	NULL
amplification	NULL
products	NULL
derived	NULL
from	NULL
specific	NULL
Ly-49	NULL
genes	NULL
and	NULL
to	NULL
include	NULL
known	NULL
cDNA	NULL
sequence	NULL
.	NULL

This	NULL
allowed	NULL
the	NULL
assignment	NULL
of	NULL
upstream	NULL
sequences	NULL
to	NULL
given	NULL
Ly-49	NULL
cDNAs	NULL
.	NULL

Because	NULL
very	NULL
little	NULL
sequence	NULL
information	NULL
was	NULL
available	NULL
for	NULL
Ly-49d	NULL
exon	NULL
I	NULL
,	NULL
we	NULL
have	NULL
used	NULL
the	NULL
amplified	NULL
genomic	NULL
Ly-49d	NULL
sequence	NULL
to	NULL
design	NULL
an	NULL
additional	NULL
sense	NULL
primer	NULL
.	NULL

This	NULL
primer	NULL
was	NULL
used	NULL
then	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
Ly-49d-specific	NULL
primer	NULL
(	NULL
36	NULL
)	NULL
on	NULL
B6	NULL
NK	NULL
cell	NULL
cDNA	NULL
templates	NULL
to	NULL
obtain	NULL
additional	NULL
5'-untranslated	NULL
Ly-49d	NULL
cDNA	NULL
sequence	NULL
.	NULL

This	NULL
amplification	NULL
product	NULL
was	NULL
cloned	NULL
and	NULL
sequenced	NULL
.	NULL

It	NULL
matched	NULL
the	NULL
Ly-49d	NULL
cDNA	NULL
and	NULL
confirmed	NULL
the	NULL
correct	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
Ly-49d	NULL
gene	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
obtained	NULL
with	NULL
Ly-49a	NULL
(	NULL
Xbal	NULL
(	NULL
-362	NULL
)	NULL
)	NULL
together	NULL
with	NULL
the	NULL
above	NULL
antisense	NULL
primers	NULL
,	NULL
except	NULL
for	NULL
Ly-49¢	NULL
,	NULL
for	NULL
which	NULL
only	NULL
a	NULL
shorter	NULL
fragment	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
sense	NULL
primer	NULL
Ly-49a	NULL
(	NULL
Psfl	NULL
(	NULL
-177	NULL
)	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
sense	NULL
primer	NULL
(	NULL
Ly-49a	NULL
(	NULL
EcoRI	NULL
(	NULL
-1066	NULL
)	NULL
)	NULL
further	NULL
upstream	NULL
did	NULL
not	NULL
yield	NULL
any	NULL
amplification	NULL
products	NULL
.	NULL

Moreover	NULL
,	NULL
no	NULL
specific	NULL
amplification	NULL
products	NULL
were	NULL
obtained	NULL
for	NULL
Ly-49e	NULL
and	NULL
Ly-49h	NULL
.	NULL

The	NULL
Ly-49a	NULL
sequence	NULL
(	NULL
accession	NULL
L13874	NULL
)	NULL
was	NULL
previously	NULL
reported	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
described	NULL
in	NULL
this	NULL
report	NULL
are	NULL
accessible	NULL
at	NULL
GenBank	NULL
:	NULL
Ly-49c	NULL
(	NULL
AYO26327	NULL
)	NULL
,	NULL
Ly-49d	NULL
(	NULL
AYO26324	NULL
)	NULL
,	NULL
Ly-49f	NULL
(	NULL
AYO26325	NULL
)	NULL
,	NULL
Ly-49g	NULL
(	NULL
AY026323	NULL
)	NULL
,	NULL
and	NULL
Ly-49i	NULL
(	NULL
AYO26326	NULL
)	NULL
.	NULL

They	NULL
were	NULL
initially	NULL
aligned	NULL
with	NULL
Sequencher	NULL
(	NULL
Gene	NULL
Codes	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
.	NULL

Portions	NULL
of	NULL
the	NULL
alignment	NULL
were	NULL
manually	NULL
adjusted	NULL
to	NULL
accommodate	NULL
gaps	NULL
.	NULL

5'-rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
end	NULL
(	NULL
5'-RACE	NULL
)	NULL
The	NULL
5	NULL
'	NULL
end	NULL
of	NULL
Ly-49	NULL
cDNAs	NULL
was	NULL
determined	NULL
using	NULL
5-RACE	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
IL-2-activated	NULL
NK	NULL
cells	NULL
using	NULL
TRIzol	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

cDNA	NULL
was	NULL
prepared	NULL
using	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Roche	NULL
)	NULL
and	NULL
oligo	NULL
(	NULL
dT	NULL
(	NULL
12-18	NULL
)	NULL
)	NULL
as	NULL
primer	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Tailing	NULL
of	NULL
the	NULL
5	NULL
``	NULL
cDNA	NULL
end	NULL
and	NULL
nested	NULL
PCR	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
5'-RACE	NULL
kit	NULL
(	NULL
Roche	NULL
Diagnostics	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

For	NULL
first-round	NULL
PCR	NULL
Ly-49	NULL
gene-specific	NULL
antisense	NULL
primers	NULL
are	NULL
described	NULL
previously	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
for	NULL
the	NULL
second	NULL
round	NULL
PCR	NULL
the	NULL
specific	NULL
primers	NULL
are	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
(	NULL
boldface	NULL
)	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
cloned	NULL
using	NULL
the	NULL
TA	NULL
cloning	NULL
kit	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
and	NULL
multiple	NULL
independent	NULL
clones	NULL
were	NULL
sequenced	NULL
to	NULL
determine	NULL
the	NULL
cDNA	NULL
end	NULL
.	NULL

Bent	NULL
arrows	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
indicate	NULL
preferred	NULL
transcriptional	NULL
start	NULL
sites	NULL
.	NULL

These	NULL
correspond	NULL
to	NULL
three	NULL
of	NULL
four	NULL
clones	NULL
for	NULL
Ly-49g	NULL
(	NULL
one	NULL
clone	NULL
ended	NULL
~50	NULL
nt	NULL
more	NULL
3	NULL
``	NULL
)	NULL
,	NULL
three	NULL
of	NULL
five	NULL
(	NULL
5	NULL
'	NULL
arrow	NULL
)	NULL
and	NULL
two	NULL
of	NULL
five	NULL
(	NULL
3'arrow	NULL
)	NULL
for	NULL
Ly-49d	NULL
,	NULL
and	NULL
two	NULL
of	NULL
three	NULL
for	NULL
Ly-49¢	NULL
(	NULL
one	NULL
clone	NULL
ended	NULL
~50	NULL
nt	NULL
more	NULL
3	NULL
'	NULL
)	NULL
.	NULL

Deletion	NULL
,	NULL
insertion	NULL
,	NULL
and	NULL
mutation	NULL
constructs	NULL
Deletion	NULL
,	NULL
insertion	NULL
,	NULL
and	NULL
mutation	NULL
constructs	NULL
were	NULL
generated	NULL
by	NULL
sequential	NULL
PCR	NULL
using	NULL
the	NULL
appropriate	NULL
genomic	NULL
clone	NULL
as	NULL
a	NULL
template	NULL
and	NULL
the	NULL
flanking	NULL
oligos	NULL
(	NULL
shown	NULL
above	NULL
)	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
primers	NULL
shown	NULL
below	NULL
.	NULL

Deletion	NULL
of	NULL
20	NULL
bp	NULL
from	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
that	NULL
eliminates	NULL
TCF	NULL
site	NULL
II	NULL
:	NULL
Only	NULL
the	NULL
sense	NULL
primer	NULL
is	NULL
shown	NULL
,	NULL
-118	NULL
CTg	NULL
gCA	NULL
CAA	NULL
TAC	NULL
gTT	NULL
ACT	NULL
TCA	NULL
ggT	NULL
TTC	NULL
ATT	NULL
Aag	NULL
Cag	NULL
-63	NULL
.	NULL

Insertion	NULL
of	NULL
20	NULL
bp	NULL
from	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
into	NULL
the	NULL
Ly-49f	NULL
promoter	NULL
(	NULL
insertion	NULL
bold	NULL
)	NULL
:	NULL
sense	NULL
,	NULL
5	NULL
``	NULL
-TCT	NULL
CTC	NULL
CTT	NULL
TgT	NULL
TCT	NULL
CAg	NULL
GG	NULL
TCA	NULL
gAT	NULL
TgC	NULL
AAT	NULL
Aag	NULL
CAA	NULL
TTT	NULL
CC	NULL
;	NULL
antisense	NULL
,	NULL
CCT	NULL
Cag	NULL
AAC	NULL
AAA	NULL
ggA	NULL
gAg	NULL
A	NULL
AAC	NULL
AAC	NULL
ATA	NULL
TAg	NULL
TAT	NULL
Cag	NULL
gTg	NULL
g.	NULL
Mutation	NULL
of	NULL
TCF	NULL
site	NULL
I	NULL
:	NULL
Only	NULL
the	NULL
sense	NULL
primer	NULL
is	NULL
shown	NULL
;	NULL
the	NULL
region	NULL
containing	NULL
TCF	NULL
site	NULL
I	NULL
is	NULL
underlined	NULL
(	NULL
introduced	NULL
mutations	NULL
bold	NULL
)	NULL
.	NULL

Ly-492	NULL
,	NULL
CTCTTTTTGATT	NULL
TGTCGACGAGGAGGAGC	NULL
;	NULL
Iy49	NULL
,	NULL
CTCTTTITGATTITGTCGAAGAG	NULL
GAGG	NULL
;	NULL
Ly-49	NULL
,	NULL
CTCTTTTTGATTTGTCGACAAGGAGG	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
All	NULL
constructs	NULL
were	NULL
sequenced	NULL
to	NULL
ensure	NULL
that	NULL
only	NULL
the	NULL
intended	NULL
mutations	NULL
were	NULL
introduced	NULL
.	NULL

Transfections	NULL
and	NULL
reporter	NULL
gene	NULL
assays	NULL
The	NULL
5	NULL
'	NULL
region	NULL
(	NULL
-362	NULL
(	NULL
Xbal	NULL
)	NULL
to	NULL
+44	NULL
(	NULL
EcoRV	NULL
)	NULL
)	NULL
of	NULL
the	NULL
Ly-49a	NULL
gene	NULL
(	NULL
35	NULL
)	NULL
or	NULL
corresponding	NULL
fragments	NULL
from	NULL
the	NULL
other	NULL
Ly-49	NULL
genes	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
luciferase	NULL
(	NULL
luc	NULL
)	NULL
reporter	NULL
plasmid	NULL
pGL3	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Ten	NULL
million	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
luc	NULL
plasmid	NULL
or	NULL
a	NULL
promoter-less	NULL
luc	NULL
construct	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
a	NULL
SV40	NULL
promoter	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
plasmid	NULL
was	NULL
included	NULL
to	NULL
control	NULL
for	NULL
the	NULL
transfection	NULL
effi-ciency	NULL
.	NULL

After	NULL
36	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
GFP	NULL
expression	NULL
using	NULL
flow	NULL
cytometry	NULL
or	NULL
lysed	NULL
to	NULL
measure	NULL
luc	NULL
activity	NULL
(	NULL
Promega	NULL
,	NULL
Walliselleu	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Specific	NULL
reporter	NULL
gene	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
a	NULL
promoter-less	NULL
luc	NULL
construct	NULL
.	NULL

Values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
percentage	NULL
of	NULL
GFP*	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Results	NULL
Ly-49	NULL
receptor	NULL
usage	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
lacking	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
Besides	NULL
the	NULL
striking	NULL
effect	NULL
on	NULL
Ly-49A	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
observed	NULL
additional	NULL
,	NULL
but	NULL
more	NULL
subtle	NULL
alterations	NULL
of	NULL
Ly-49	NULL
receptor	NULL
usage	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
NK	NULL
cell	NULL
receptor	NULL
repertoire	NULL
in	NULL
these	NULL
mice	NULL
was	NULL
skewed	NULL
based	NULL
on	NULL
Ly-49/MHC	NULL
class	NULL
I	NULL
interactions	NULL
,	NULL
we	NULL
generated	NULL
double-deficient	NULL
mice	NULL
,	NULL
which	NULL
lack	NULL
TCF-1	NULL
as	NULL
well	NULL
as	NULL
class	NULL
I	NULL
MHC	NULL
molecules	NULL
(	NULL
due	NULL
to	NULL
the	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
Bam	NULL
gene	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
class	NULL
I	NULL
MHC	NULL
molecules	NULL
,	NULL
the	NULL
Ly-49	NULL
receptor	NULL
repertoire	NULL
of	NULL
TCF-1*	NULL
and	NULL
TCF-1~	NULL
mice	NULL
was	NULL
significantly	NULL
different	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
Ly-49A-expressing	NULL
NK	NULL
cells	NULL
was	NULL
reduced	NULL
~10-	NULL
to	NULL
20-fold	NULL
in	NULL
Tef-I	NULL
mutant	NULL
as	NULL
compared	NULL
with	NULL
wild-type	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Ly-49C/I-expressing	NULL
NK	NULL
cells	NULL
(	NULL
identified	NULL
by	NULL
mAb	NULL
5B6	NULL
)	NULL
were	NULL
significantly	NULL
more	NULL
abundant	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
.	NULL

This	NULL
,	NULL
together	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
Ly-49C	NULL
subset	NULL
(	NULL
identified	NULL
by	NULL
mAb	NULL
4L0431	NULL
)	NULL
was	NULL
not	NULL
significantly	NULL
altered	NULL
,	NULL
suggests	NULL
a	NULL
positive	NULL
effect	NULL
on	NULL
Ly-49I	NULL
usage	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
.	NULL

Similarly	NULL
,	NULL
Ly-49G	NULL
usage	NULL
was	NULL
increased	NULL
,	NULL
while	NULL
the	NULL
NK	NULL
cell	NULL
subset	NULL
defined	NULL
by	NULL
the	NULL
activating	NULL
Ly-49D	NULL
receptor	NULL
was	NULL
reduced	NULL
~3-fold	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
,	NULL
TCF-1	NULL
deficiency	NULL
results	NULL
in	NULL
positive	NULL
and	NULL
negative	NULL
effects	NULL
on	NULL
Ly-49	NULL
receptor	NULL
usage	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
it	NULL
is	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
or	NULL
of	NULL
Ly-49A	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
altered	NULL
representation	NULL
of	NULL
the	NULL
remaining	NULL
Ly-49	NULL
receptors	NULL
,	NULL
we	NULL
have	NULL
generated	NULL
Ly-49A	NULL
transgenic	NULL
,	NULL
TCF-1-deficient	NULL
mice	NULL
.	NULL

Transgene	NULL
expression	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
endogenous	NULL
Ly-49	NULL
usage	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
Ly-49	NULL
receptor	NULL
repertoire	NULL
is	NULL
skewed	NULL
due	NULL
to	NULL
TCF-1	NULL
,	NULL
and	NULL
not	NULL
indirectly	NULL
due	NULL
to	NULL
Ly-49A	NULL
deficiency	NULL
.	NULL

Finally	NULL
,	NULL
NK	NULL
cells	NULL
seem	NULL
to	NULL
express	NULL
distinct	NULL
Ly-49	NULL
receptors	NULL
in-dependently	NULL
,	NULL
based	NULL
on	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
extent	NULL
of	NULL
receptor	NULL
coexpression	NULL
fits	NULL
well	NULL
with	NULL
coincident	NULL
coexpression	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
the	NULL
sizes	NULL
of	NULL
individual	NULL
Ly-49-defined	NULL
NK	NULL
cell	NULL
subsets	NULL
are	NULL
significantly	NULL
altered	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
,	NULL
coexpression	NULL
of	NULL
Ly-49	NULL
receptors	NULL
was	NULL
still	NULL
observed	NULL
at	NULL
the	NULL
expected	NULL
frequencies	NULL
,	NULL
which	NULL
indicate	NULL
independent	NULL
regulation	NULL
of	NULL
Ly-49	NULL
receptors	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
Ly-49A	NULL
acquisition	NULL
from	NULL
the	NULL
endogenous	NULL
locus	NULL
does	NULL
not	NULL
per	NULL
se	NULL
affect	NULL
the	NULL
acquisition	NULL
of	NULL
other	NULL
Ly-49	NULL
receptors	NULL
,	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
TCF-1	NULL
does	NULL
not	NULL
globally	NULL
alter	NULL
Ly-49	NULL
coexpression	NULL
patterns	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
TCP-1	NULL
independently	NULL
affects	NULL
the	NULL
acquisition	NULL
of	NULL
multiple	NULL
Ly-49	NULL
receptors	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL

Isolation	NULL
and	NULL
analysis	NULL
of	NULL
Ly-49	NULL
promoter	NULL
regions	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
TCF-1	NULL
dependence	NULL
of	NULL
Ly-49A	NULL
acquisition	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
TCF	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
proximal	NULL
Ly-49a	NULL
promoter	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
begin	NULL
to	NULL
assess	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
altered	NULL
usage	NULL
of	NULL
other	NULL
Ly-49	NULL
family	NULL
receptors	NULL
in	NULL
TCP-1	NULL
6183	NULL
Tef-1/-	NULL
B2m-/-	NULL
A	NULL
Tef1+/+	NULL
BZm'/	NULL
'	NULL
R	NULL
i	NULL
__	NULL
i	NULL
Cell	NULL
number	NULL
T4	NULL
to	NULL
to	NULL
Ly49A	NULL
(	NULL
JR9-318	NULL
)	NULL
90	NULL
x	NULL
*	NULL
TCEA	NULL
+/+	NULL
B	NULL
-	NULL
so	NULL
i	NULL
I	NULL
0	NULL
bam	NULL
&	NULL
703	NULL
_I	NULL
;	NULL
L	NULL
§	NULL
60	NULL
]	NULL
1	NULL
TCB1~/-¥	NULL
50	NULL
]	NULL
T	NULL
i	NULL
B2	NULL
-/-Z	NULL
407	NULL
+	NULL
m	NULL
6	NULL
30	NULL
{	NULL
®	NULL
29	NULL
/t	NULL
x	NULL
103	NULL
]	NULL
|	NULL
0	NULL
t*	NULL
T	NULL
t	NULL
t	NULL
t	NULL
®	NULL
oC	NULL
Y	NULL
V	NULL
“	NULL
Q	NULL
``	NULL
¥	NULL
o	NULL
a3	NULL
xfs	NULL
TCFA+/+	NULL
C	NULL
_	NULL
__..	NULL
|	NULL
10.8	NULL
0.73	NULL
t	NULL
{	NULL
a	NULL
(	NULL
125	NULL
)	NULL
(	NULL
0.77	NULL
)	NULL
18	NULL
54	NULL
f	NULL
O	NULL
1.3	NULL
a	NULL
30:4	NULL
)	NULL
...	NULL
..	NULL
0:4	NULL
Prin	NULL
2	NULL
aia	NULL
r	NULL
rrm	NULL
2	NULL
Ly49A	NULL
(	NULL
JR9-318	NULL
)	NULL
FIGURE	NULL
1	NULL
.	NULL

Ly-49	NULL
receptor	NULL
usage	NULL
in	NULL
B	NULL
,	NULL
m/TCF-1	NULL
double-deficient	NULL
mice	NULL
.	NULL

A	NULL
,	NULL
Splenocytes	NULL
from	NULL
TCF-1/B	NULL
,	NULL
m	NULL
double-deficient	NULL
mice	NULL
were	NULL
enriched	NULL
for	NULL
NK	NULL
cells	NULL
by	NULL
nylon	NULL
wool	NULL
nonadherence	NULL
and	NULL
stained	NULL
with	NULL
mAbs	NULL
against	NULL
CD3	NULL
and	NULL
NK1.1	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Percentage	NULL
of	NULL
Ly-49A*	NULL
cells	NULL
was	NULL
determined	NULL
among	NULL
CD3~	NULL
NK1.1*	NULL
NK	NULL
cells	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Bar	NULL
graphs	NULL
depict	NULL
the	NULL
percentage	NULL
of	NULL
Ly-49*	NULL
NK	NULL
cells	NULL
among	NULL
CD3~	NULL
NK1.1*	NULL
NK	NULL
cells	NULL
in	NULL
spleens	NULL
of	NULL
seven	NULL
or	NULL
more	NULL
mice	NULL
of	NULL
the	NULL
indicated	NULL
genotypes	NULL
.	NULL

Ly-49C	NULL
estimates	NULL
represent	NULL
single	NULL
determinations	NULL
.	NULL

Corresponding	NULL
results	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
no	NULL
difference	NULL
in	NULL
Ly-49C	NULL
usage	NULL
between	NULL
TCF-1*	NULL
and	NULL
TCF-1~	NULL
mice	NULL
,	NULL
were	NULL
obtained	NULL
in	NULL
H-2°	NULL
and	NULL
H-2	NULL
``	NULL
``	NULL
background	NULL
mice	NULL
.	NULL

*	NULL
,	NULL
Indicates	NULL
statistically	NULL
significant	NULL
differences	NULL
(	NULL
p	NULL
<	NULL
0.001	NULL
)	NULL
between	NULL
TCF-1~	NULL
NK	NULL
cells	NULL
of	NULL
B	NULL
,	NULL
m-sufficient	NULL
and	NULL
B	NULL
,	NULL
;	NULL
m-deficient	NULL
mice	NULL
.	NULL

C	NULL
,	NULL
Ly-49	NULL
receptor	NULL
coexpression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
Ly-49A	NULL
vs	NULL
Ly-49C/I	NULL
usage	NULL
was	NULL
determined	NULL
among	NULL
gated	NULL
splenic	NULL
CD37	NULL
NK1.1*	NULL
NK	NULL
cells	NULL
of	NULL
TCF-1-deficient	NULL
and	NULL
TCF-1-sufficient	NULL
H-2	NULL
``	NULL
mice	NULL
.	NULL

Numbers	NULL
indicate	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
in	NULL
the	NULL
respective	NULL
quadrants	NULL
.	NULL

The	NULL
number	NULL
in	NULL
brackets	NULL
depicts	NULL
the	NULL
expected	NULL
frequency	NULL
of	NULL
double	NULL
expressors	NULL
if	NULL
coexpression	NULL
coincides	NULL
.	NULL

This	NULL
number	NULL
corresponds	NULL
to	NULL
the	NULL
product	NULL
of	NULL
the	NULL
Ly-49A	NULL
and	NULL
Ly-49C/I	NULL
frequencies	NULL
.	NULL

deficient	NULL
mice	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
upstream	NULL
regions	NULL
of	NULL
five	NULL
additional	NULL
Ly-49	NULL
genes	NULL
.	NULL

This	NULL
was	NULL
achieved	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
in	NULL
combination	NULL
with	NULL
primers	NULL
for	NULL
individual	NULL
Ly-49	NULL
genes	NULL
,	NULL
allowing	NULL
us	NULL
to	NULL
PCR	NULL
amplify	NULL
Ly-49	NULL
upstream	NULL
regions	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6184	NULL
R	NULL
X	NULL
-	NULL
P	NULL
TCF	NULL
tsp	NULL
V	NULL
+1046	NULL
-362	NULL
-177	NULL
II	NULL
I	NULL
+1	NULL
+44	NULL
Ly49	NULL
@	NULL
-	NULL
>	NULL
>	NULL
-	NULL
<	NULL
[	NULL
TCF	NULL
site	NULL
CTTTGA/TA/T	NULL
FIGURE	NULL
2	NULL
.	NULL

Strategy	NULL
to	NULL
isolate	NULL
Ly-49	NULL
promoters	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
Ly-49a	NULL
upstream	NULL
region	NULL
.	NULL

Restriction	NULL
sites	NULL
(	NULL
R	NULL
,	NULL
EcoRI	NULL
;	NULL
X	NULL
,	NULL
Xbal	NULL
,	NULL
P	NULL
,	NULL
Psfl	NULL
;	NULL
V	NULL
,	NULL
EcoRV	NULL
)	NULL
and	NULL
their	NULL
position	NULL
relative	NULL
to	NULL
the	NULL
tsp	NULL
are	NULL
shown	NULL
(	NULL
not	NULL
to	NULL
scale	NULL
)	NULL
(	NULL
22	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Open	NULL
boxes	NULL
represent	NULL
consensus	NULL
CTTTGA/TA/T	NULL
motifs	NULL
that	NULL
can	NULL
bind	NULL
frans-acting	NULL
factors	NULL
such	NULL
as	NULL
TCF-1	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
Ly-49a-specific	NULL
sense	NULL
primers	NULL
that	NULL
were	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
antisense	NULL
primers	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
complementary	NULL
to	NULL
the	NULL
5	NULL
'	NULL
-untranslated	NULL
regions	NULL
of	NULL
the	NULL
respective	NULL
Ly-49	NULL
cDNAs	NULL
.	NULL

For	NULL
further	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

from	NULL
genomic	NULL
B6	NULL
DNA	NULL
templates	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
longest	NULL
amplification	NULL
products	NULL
obtained	NULL
were	NULL
~400	NULL
bp	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
Xbal-EcoRV	NULL
fragment	NULL
of	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

For	NULL
Ly-49c	NULL
,	NULL
we	NULL
obtained	NULL
a	NULL
shorter	NULL
,	NULL
200-bp	NULL
upstream	NULL
fragment	NULL
corre-	NULL
TCF-1	NULL
DEPENDENCE	NULL
OF	NULL
THE	NULL
Ly-49	NULL
RECEPTOR	NULL
REPERTOIRE	NULL
sponding	NULL
to	NULL
the	NULL
Psfl-EcoRV	NULL
fragment	NULL
of	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
.	NULL

The	NULL
alignment	NULL
of	NULL
Ly-49a	NULL
with	NULL
the	NULL
novel	NULL
sequences	NULL
revealed	NULL
three	NULL
patterns	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

First	NULL
,	NULL
Ly-49a-like	NULL
sequences	NULL
include	NULL
Ly-49c	NULL
and	NULL
Ly-49g	NULL
.	NULL

These	NULL
sequences	NULL
contain	NULL
two	NULL
consensus	NULL
TCF-1	NULL
binding	NULL
sites	NULL
(	NULL
CTTTGA/TA/T	NULL
)	NULL
that	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
TCF	NULL
I	NULL
and	NULL
II	NULL
.	NULL

Second	NULL
,	NULL
Ly-49c-like	NULL
sequences	NULL
(	NULL
including	NULL
Ly-49c¢	NULL
,	NULL
Ly-49f	NULL
,	NULL
and	NULL
Ly-497	NULL
)	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
20-bp	NULL
deletion	NULL
that	NULL
comprises	NULL
in	NULL
its	NULL
center	NULL
and	NULL
consequently	NULL
eliminates	NULL
TCF	NULL
site	NULL
II	NULL
.	NULL

TCF	NULL
site	NULL
I	NULL
is	NULL
retained	NULL
in	NULL
Ly49i	NULL
and	NULL
Ly-49f	NULL
,	NULL
but	NULL
mutant	NULL
in	NULL
Ly-49c	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
Ly-49d	NULL
upstream	NULL
region	NULL
resembles	NULL
Ly-49a	NULL
(	NULL
ie	NULL
.	NULL

,	NULL
it	NULL
contains	NULL
the	NULL
above	NULL
20-bp	NULL
se-quence	NULL
)	NULL
;	NULL
however	NULL
,	NULL
both	NULL
consensus	NULL
TCF	NULL
sites	NULL
are	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
and	NULL
schematic	NULL
representation	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Because	NULL
Ly-49D	NULL
usage	NULL
is	NULL
significantly	NULL
reduced	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
,	NULL
these	NULL
latter	NULL
findings	NULL
suggest	NULL
that	NULL
TCF-1-dependent	NULL
effects	NULL
may	NULL
also	NULL
be	NULL
indirect	NULL
(	NULL
ie	NULL
.	NULL

,	NULL
based	NULL
on	NULL
deregulated	NULL
expression	NULL
of	NULL
additional	NULL
transcription	NULL
fac-tors	NULL
)	NULL
or	NULL
be	NULL
exerted	NULL
by	NULL
TCF-1	NULL
binding	NULL
to	NULL
cis-acting	NULL
elements	NULL
that	NULL
are	NULL
located	NULL
elsewhere	NULL
in	NULL
the	NULL
gene	NULL
.	NULL

A	NULL
preliminary	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
Ly-49	NULL
cDNAs	NULL
identified	NULL
preferred	NULL
transcriptional	NULL
start	NULL
points	NULL
(	NULL
tsps	NULL
)	NULL
in	NULL
several	NULL
Ly-49	NULL
genes	NULL
.	NULL

These	NULL
are	NULL
located	NULL
in	NULL
83	NULL
%	NULL
of	NULL
all	NULL
clones	NULL
18-22	NULL
nt	NULL
downstream	NULL
of	NULL
the	NULL
CTAGCATAAT	NULL
TCAAAATGAA	NULL
GAAATAACTT	NULL
AAAAA-TTAG	NULL
TAACATAATA	NULL
-271	NULL
TTAGAATAAT	NULL
TCAAAATGAA	NULL
GAAATAACTT	NULL
AAAAA-TTAG	NULL
AAACATAATA	NULL
TTAACATGAT	NULL
TCAACATCAA	NULL
AACATTAATA	NULL
TAAAAAATAG	NULL
CAACATAATA	NULL
TTAGCATAAT	NULL
TCTAATTCAA	NULL
GGAATAACTA	NULL
AAAAA-ATAG	NULL
TAACTTAAAT	NULL
TTAGCATAAT	NULL
TCAAAATCAA	NULL
GGAGTAACTA	NULL
AAAAA	NULL
--	NULL
TAG	NULL
TAACATAACA	NULL
--	NULL
ATTACAAA	NULL
-	NULL
AGCATCAGTG	NULL
CCACATTTTT	NULL
CCAAGTTGTT	NULL
-209	NULL
TAATTACAAA	NULL
ACAAGG	NULL
--	NULL
--	NULL
AGCATCAGTC	NULL
CCACATTTTT	NULL
CCTAGTTGTT	NULL
ACAAGT	NULL
--	NULL
--	NULL
--	NULL
-TTTAAGT	NULL
CCATCTTTTT	NULL
CCCAATGGTT	NULL
--	NULL
ATGACAAA	NULL
ATTA	NULL
TAC	NULL
GAACT	NULL
CT	NULL
C	NULL
A	NULL
CCACTTTTT	NULL
CCTATTTGTT	NULL
8	NULL
--	NULL
ATGACAAA	NULL
ATTAGCCTAT	NULL
GAACTTCAGT	NULL
CCCTCTTTTT	NULL
CCTATTTGTT	NULL
TTCTTAAAAA	NULL
TATCAGTTAT	NULL
GGACATTTGT	NULL
TTTGCAGCAT	NULL
CTGGCACAAT	NULL
-109	NULL
GTCTTAAAAA	NULL
TATCAGTTAT	NULL
GGACATTTGT	NULL
TTTGCAGCAT	NULL
CTGGCACAAT	NULL
GTCTTC-AAA	NULL
TATCATATAT	NULL
AGTCATTTCT	NULL
TTTGCAGCAT	NULL
CTGGCAAAAT	NULL
GTCTTC-AAA	NULL
TATAAATTAT	NULL
TCACATTTGT	NULL
TTTGTC-CAC	NULL
CTGATACTAT	NULL
ATCTTC-AAA	NULL
TATAAATTAT	NULL
TCACATTTGT	NULL
TTTGTC-CAT	NULL
CCAATACTAT	NULL
ATCTTC-AAA	NULL
TATAAATCAT	NULL
TCACATTTGT	NULL
TTTGTC-CAT	NULL
CCAATACTAT	NULL
ATF-2	NULL
TCF	NULL
1	NULL
``	NULL
TATA	NULL
``	NULL
CTCTTTTTG	NULL
CTCTTTTTG	NULL
CTCTTTTTGA	NULL
TTTGGTCAAG	NULL
CTCTTTTTGC	NULL
TETGATEAAG	NULL
C	NULL
'	NULL
I'CTTT	NULL
’	NULL
I	NULL
”	NULL
I	NULL
‘	NULL
(	NULL
§ACA	NULL
CTCTTTTTGC	NULL
TTrGeTGace	NULL
AGGTTGAGTA	NULL
-9	NULL
G	NULL
AGGTTGAGTA	NULL
GAAAACCATG	NULL
AGATTGAGTG	NULL
GAAAATCATG	NULL
AGGTTGAGTA	NULL
GARAATCATG	NULL
AGATTGAGTA	NULL
GAAAATCATG	NULL
AGGTTGAGTA	NULL
EcoRV	NULL
GATATCAACC	NULL
AG	NULL
AAAGCC	NULL
AACTTTITTCCTCCACCAGAAC	NULL
CACTITCTTGC	NULL
AACTTTTTCT	NULL
CCACAGGAAT	NULL
CACTTCTCAG	NULL
GATATCA	NULL
Ly49a	NULL
conc	NULL
ccc	NULL
cns	NULL
Cac	NULL
Ly49g	NULL
=	NULL
-	NULL
...	NULL
.0	NULL
>	NULL
TAC	NULL
Ly49d	NULL
_	NULL
AGTGGAAATG	NULL
TGCTT	NULL
--	NULL
-TA	NULL
AAGGCATTTC	NULL
TAATACACAC	NULL
TAAGATGCAA	NULL
Ly49f	NULL
AGTGGAAATG	NULL
TGAGTGCTCA	NULL
AAAGCATTCT	NULL
TAATATATAC	NULL
TTAGCTGCAA	NULL
Ly49i	NULL
AGTGCAAATG	NULL
TGAGTGCTTA	NULL
AAAGCATTCC	NULL
TAATATATAC	NULL
TTAGCTCCAA	NULL
Ly49a	NULL
_	NULL
GTAAATTTCC	NULL
AACAGTCT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Ly49g	NULL
-	NULL
GTAAATTTCC	NULL
AAAATTACAA	NULL
ATTACAAATT	NULL
ATAATTTAAA	NULL
TTACAAATTA	NULL
Ly49d	NULL
_	NULL
GAAGATTTCC	NULL
AAAAGTCGAA	NULL
TAAAAAATT-	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Ly49f	NULL
GTA-ATTTCC	NULL
AACAGTCT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-=-	NULL
>	NULL
Ly49i	NULL
GTAAATTTCA	NULL
AACAGTTT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
>	NULL
--	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
Pst	NULL
I	NULL
Ly49a	NULL
TTGCTAAGGA	NULL
CAGTGTTTTT	NULL
carorreres	NULL
Ly49g	NULL
TTGCTAAGGA	NULL
TAGTGTTTTT	NULL
carorrerct	NULL
Ly49d	NULL
TTGCTAAAGA	NULL
CACAGGTTTT	NULL
gaTerrTrer	NULL
Ly49f	NULL
TTGCTAAAGA	NULL
CAATGCTTTC	NULL
f	NULL
carcatere	NULL
?	NULL

Ly49i	NULL
TTGCTAAAGA	NULL
CAATGTTTTC	NULL
CC-CTCTCTG	NULL
CAGGAGTGTG	NULL
TGTCTTCTCT	NULL
Ly49c	NULL
Ly49a	NULL
ACGTTACTTC	NULL
AAGCAGTTTC	NULL
Ly49g	NULL
ATGTTTCTTC	NULL
C	NULL
AGGTTTCATT	NULL
AAGCAGTTTC	NULL
Ly49d	NULL
ATTTTGCTTC	NULL
TTTCCCTTGC	NULL
CTTCAGACTC	NULL
AGCTTTCAAA	NULL
AG-CAATTTC	NULL
Ly49f	NULL
ATGTTGTRe-	NULL
TC	NULL
AGATTGCAAT	NULL
AAGCAATTTC	NULL
Ly4a9i	NULL
ATOTT	NULL
@	NULL
PTce	NULL
secccccccs	NULL
TT	NULL
AGATTGCAAT	NULL
AAGCAATTTC	NULL
Ly49c	NULL
ETOTTORYL	NULL
.	NULL

TC	NULL
AGATTGCAAT	NULL
AAGCAATTTC	NULL
tsp	NULL
+1	NULL
Ly49a	NULL
TCTCTCAG'II	NULL
‘	NULL
G	NULL
GAAATTTAGT	NULL
TCT-ACC	NULL
@	NULL
IT	NULL
TATTTTGGAG	NULL
ACACTTAGGG	NULL
Ly49g	NULL
TCACTCAGTG	NULL
GAAATTTAGT	NULL
TcmAchéT	NULL
TATTTIGGAG	NULL
ACACTTAGGG	NULL
Ly49d	NULL
TTGCTCAGAG	NULL
GAAATTTAGT	NULL
TCTGCQ	NULL
’	NULL
FEC	NULL
T-	NULL
TCTTGGAG	NULL
C	NULL
Ly49Ff	NULL
TCACTCGGTG	NULL
GAAATTTAGT	NULL
TCTGTCTTTC	NULL
ATTTTTGAAA	NULL
C-TTGT	NULL
Ly49i	NULL
TCACTCGGTG	NULL
GAAATTTAGC	NULL
TCTGTCTIITC	NULL
AATTTTGAAA	NULL
c	NULL
Ly49c	NULL
TCACCCGGTG	NULL
GAAATTTAGT	NULL
TCCGAEETﬁTL	NULL
‘	NULL
AATTTTGAAA	NULL
CTCGTAGGAG	NULL
Ly499	NULL
T	NULL
AGAGA	NULL
Ly49d	NULL
TCTACCCACC	NULL
TCACTTCAGG	NULL
TAGAGTCACA	NULL
GGTAACAATA	NULL
A	NULL
Ly4	NULL
%	NULL
c	NULL
CATCACTCCG	NULL
GTAGAGACAC	NULL
GATACAC	NULL
CACATTACCC	NULL
C	NULL
AACTCTACAG	NULL
TCAAATTTTC	NULL
CCTCACCA	NULL
CAACAGGGAC	NULL
ATCCATTCCT	NULL
GATATAG	NULL
ATC-TAAACC	NULL
AGAAA	NULL
s	NULL
n	NULL
m	NULL
lel	NULL
o	NULL
AACGTTTCAG	NULL
ACAAATTTTC	NULL
CCTCCACCAG	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Alignment	NULL
of	NULL
Ly-49	NULL
5	NULL
-flanking	NULL
sequences	NULL
.	NULL

Ly-49	NULL
upstream	NULL
regions	NULL
are	NULL
aligned	NULL
with	NULL
the	NULL
corresponding	NULL
Ly-49a	NULL
sequence	NULL
.	NULL

The	NULL
numbering	NULL
is	NULL
relative	NULL
to	NULL
the	NULL
tsp	NULL
of	NULL
Ly-49a	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
first	NULL
base	NULL
shown	NULL
corresponds	NULL
to	NULL
-344	NULL
in	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
28	NULL
bp	NULL
downstream	NULL
of	NULL
the	NULL
Xbal	NULL
site	NULL
in	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
.	NULL

All	NULL
sequences	NULL
except	NULL
for	NULL
Ly-49¢	NULL
contain	NULL
these	NULL
28	NULL
bp	NULL
from	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
due	NULL
to	NULL
the	NULL
primer	NULL
used	NULL
for	NULL
amplification	NULL
.	NULL

The	NULL
location	NULL
of	NULL
gene-specific	NULL
antisense	NULL
primers	NULL
is	NULL
shown	NULL
in	NULL
boldface	NULL
.	NULL

Dashes	NULL
(	NULL
-	NULL
)	NULL
indicate	NULL
the	NULL
absence	NULL
of	NULL
nucleotides	NULL
.	NULL

Previously	NULL
available	NULL
B6-derived	NULL
cDNA	NULL
sequences	NULL
are	NULL
underlined	NULL
.	NULL

Gray	NULL
boxes	NULL
depict	NULL
consensus	NULL
TCF-binding	NULL
motifs	NULL
(	NULL
CTTTGA/TA/T	NULL
)	NULL
(	NULL
TCF	NULL
I	NULL
and	NULL
TCF	NULL
II	NULL
)	NULL
.	NULL

The	NULL
open	NULL
box	NULL
depicts	NULL
an	NULL
ATF-2	NULL
binding	NULL
site	NULL
,	NULL
shown	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
tsp	NULL
of	NULL
Ly-49a	NULL
was	NULL
previously	NULL
determined	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Bent	NULL
arrows	NULL
indicate	NULL
tsps	NULL
that	NULL
were	NULL
determined	NULL
in	NULL
this	NULL
study	NULL
using	NULL
5	NULL
``	NULL
-RACE	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
5	NULL
cDNA	NULL
ends	NULL
,	NULL
a	NULL
potential	NULL
TATA-like	NULL
core	NULL
promoter	NULL
element	NULL
identified	NULL
in	NULL
Ly-49a	NULL
(	NULL
ATAAA	NULL
,	NULL
depicted	NULL
as	NULL
TATA	NULL
)	NULL
(	NULL
35	NULL
)	NULL
is	NULL
also	NULL
present	NULL
in	NULL
Ly-49g	NULL
.	NULL

This	NULL
motif	NULL
is	NULL
mutant	NULL
in	NULL
all	NULL
other	NULL
Ly-49	NULL
promoter	NULL
regions	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
represent	NULL
TATA-less	NULL
promoters	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
TCF	NULL
X	NULL
P	NULL
III	NULL
0	NULL
_	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
Fold	NULL
specific	NULL
activation	NULL
FIGURE	NULL
4	NULL
.	NULL

Reporter	NULL
gene	NULL
activation	NULL
by	NULL
Ly-49	NULL
promoters	NULL
.	NULL

Approximately	NULL
400	NULL
bp	NULL
of	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
various	NULL
Ly-49	NULL
genes	NULL
were	NULL
fused	NULL
to	NULL
a	NULL
luciferase	NULL
(	NULL
luc	NULL
)	NULL
reporter	NULL
gene	NULL
.	NULL

Rectangles	NULL
indicate	NULL
the	NULL
location	NULL
of	NULL
consensus	NULL
TCF	NULL
sites	NULL
,	NULL
circles	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
putative	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
thin	NULL
line	NULL
bridging	NULL
gaps	NULL
indicates	NULL
deletions	NULL
.	NULL

Resulting	NULL
plasmids	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
EL-4	NULL
thymoma	NULL
or	NULL
A20	NULL
B	NULL
lymphoma	NULL
cells	NULL
.	NULL

Specific	NULL
reporter	NULL
gene	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
a	NULL
promoter-less	NULL
luc	NULL
construct	NULL
.	NULL

Data	NULL
indicate	NULL
mean	NULL
of	NULL
fold-specific	NULL
induction	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
experiments	NULL
.	NULL

one	NULL
previously	NULL
reported	NULL
for	NULL
Ly-49a	NULL
(	NULL
bent	NULL
arrows	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Ly-49i	NULL
cDNAs	NULL
extended	NULL
into	NULL
the	NULL
TATA	NULL
box	NULL
region	NULL
;	NULL
however	NULL
,	NULL
this	NULL
analysis	NULL
may	NULL
have	NULL
been	NULL
biased	NULL
for	NULL
such	NULL
products	NULL
because	NULL
the	NULL
primer	NULL
covered	NULL
the	NULL
major	NULL
initiation	NULL
site	NULL
present	NULL
in	NULL
other	NULL
Ly-49	NULL
genes	NULL
.	NULL

The	NULL
data	NULL
are	NULL
compatible	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
TATA-like	NULL
(	NULL
ATAAAA	NULL
)	NULL
core	NULL
promoter	NULL
element	NULL
in	NULL
Ly-49a	NULL
and	NULL
Ly-49g	NULL
;	NULL
however	NULL
,	NULL
the	NULL
remaining	NULL
Ly-49	NULL
promoters	NULL
appear	NULL
to	NULL
be	NULL
TATA-less	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
upstream	NULL
sequences	NULL
reported	NULL
in	NULL
this	NULL
work	NULL
do	NULL
indeed	NULL
contain	NULL
promoter	NULL
elements	NULL
.	NULL

Regulation	NULL
of	NULL
Ly-49	NULL
promoters	NULL
by	NULL
TCF	NULL
site	NULL
II	NULL
To	NULL
delineate	NULL
a	NULL
role	NULL
for	NULL
TCF	NULL
binding	NULL
sites	NULL
that	NULL
are	NULL
located	NULL
in	NULL
proximal	NULL
Ly-49	NULL
promoters	NULL
,	NULL
we	NULL
have	NULL
first	NULL
compared	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
different	NULL
Ly-49	NULL
promoters	NULL
using	NULL
reporter	NULL
gene	NULL
assays	NULL
in	NULL
the	NULL
Ly-49A-expressing	NULL
T	NULL
cell	NULL
lymphoma	NULL
EL-4	NULL
.	NULL

Preliminary	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
~400-bp	NULL
(	NULL
Xbal-EcoRV	NULL
)	NULL
Ly-49a	NULL
promoter	NULL
fragment	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
efficient	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
EL-4	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
Ly-49a	NULL
,	NULL
the	NULL
Ly-49g	NULL
upstream	NULL
regions	NULL
conferred	NULL
robust	NULL
(	NULL
30-fold	NULL
)	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
EL-4	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
control	NULL
A20	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
reporter	NULL
gene	NULL
activation	NULL
by	NULL
the	NULL
Ly-49f	NULL
(	NULL
10-fold	NULL
)	NULL
and	NULL
Ly-49i	NULL
(	NULL
3-fold	NULL
)	NULL
promoters	NULL
was	NULL
considerably	NULL
less	NULL
efficient	NULL
,	NULL
while	NULL
Ly-49d	NULL
was	NULL
completely	NULL
inactive	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
functional	NULL
differences	NULL
in	NULL
reporter	NULL
gene	NULL
assays	NULL
seem	NULL
to	NULL
reflect	NULL
structural	NULL
differences	NULL
in	NULL
Ly-49	NULL
promoters	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
TCF	NULL
site	NULL
II	NULL
in	NULL
proximal	NULL
promoters	NULL
correlated	NULL
with	NULL
efficient	NULL
reporter	NULL
gene	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
point	NULL
mutations	NULL
in	NULL
TCF	NULL
site	NULL
II	NULL
significantly	NULL
reduced	NULL
Ly-49a	NULL
promoter	NULL
activity	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Natural	NULL
promoters	NULL
such	NULL
as	NULL
Ly-49c¢	NULL
,	NULL
Ly-49i	NULL
,	NULL
and	NULL
Ly-49f	NULL
lack	NULL
TCF	NULL
site	NULL
II	NULL
due	NULL
to	NULL
a	NULL
20-bp	NULL
deletion	NULL
.	NULL

To	NULL
further	NULL
address	NULL
the	NULL
importance	NULL
of	NULL
TCF	NULL
site	NULL
II	NULL
,	NULL
the	NULL
respective	NULL
20	NULL
bp	NULL
was	NULL
deleted	NULL
from	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
.	NULL

This	NULL
deletion	NULL
resulted	NULL
in	NULL
a	NULL
considerably	NULL
reduced	NULL
activity	NULL
of	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
(	NULL
~4-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
a	NULL
reciprocal	NULL
experiment	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
TCF	NULL
site	NULL
II	NULL
was	NULL
able	NULL
to	NULL
restore	NULL
strong	NULL
reporter	NULL
gene	NULL
activation	NULL
by	NULL
a	NULL
Ly-49	NULL
promoter	NULL
that	NULL
lacked	NULL
it	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
introduced	NULL
the	NULL
20	NULL
bp	NULL
of	NULL
the	NULL
Ly-49a	NULL
promoter-containing	NULL
TCF	NULL
site	NULL
II	NULL
into	NULL
Ly-49f	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
Ly-49f	NULL
insertion	NULL
construct	NULL
conferred	NULL
efficient	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
EL-4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
20-bp	NULL
stretch	NULL
is	NULL
thus	NULL
nec-	NULL
6185	NULL
Ly49a	NULL
Ly49f	NULL
Ly49f	NULL
ins	NULL
II	NULL
--	NULL
--	NULL
-	NULL
[	NULL
}	NULL
-	NULL
[	NULL
}	NULL
-=	NULL
0	NULL
_	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
Fold	NULL
specific	NULL
activation	NULL
FIGURE	NULL
5	NULL
.	NULL

Regulation	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
by	NULL
TCF	NULL
site	NULL
II	NULL
.	NULL

The	NULL
region	NULL
corresponding	NULL
to	NULL
the	NULL
20-bp	NULL
deletion	NULL
found	NULL
in	NULL
Ly-49c	NULL
,	NULL
f	NULL
,	NULL
and	NULL
,	NULL
which	NULL
includes	NULL
TCF	NULL
site	NULL
I	NULL
,	NULL
was	NULL
deleted	NULL
from	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
using	NULL
sequential	NULL
PCR	NULL
.	NULL

The	NULL
respective	NULL
20	NULL
bp	NULL
from	NULL
Ly-49a	NULL
were	NULL
inserted	NULL
into	NULL
Ly-49f	NULL
.	NULL

Rectangles	NULL
indicate	NULL
the	NULL
location	NULL
of	NULL
consensus	NULL
TCF	NULL
sites	NULL
,	NULL
circles	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
putative	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
thin	NULL
line	NULL
bridging	NULL
gaps	NULL
indicates	NULL
deletions	NULL
.	NULL

The	NULL
resulting	NULL
luc	NULL
reporter	NULL
gene	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
EL-4	NULL
and	NULL
A20	NULL
cells	NULL
.	NULL

Specific	NULL
reporter	NULL
gene	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
a	NULL
promoter-less	NULL
luc	NULL
construct	NULL
.	NULL

Data	NULL
indicate	NULL
mean	NULL
of	NULL
fold-specific	NULL
induction	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
experiments	NULL
.	NULL

essary	NULL
for	NULL
efficient	NULL
Ly-49	NULL
promoter	NULL
activity	NULL
in	NULL
EL-4	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
TCF	NULL
site	NULL
II	NULL
can	NULL
significantly	NULL
contribute	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
Ly-49	NULL
promoters	NULL
.	NULL

Regulation	NULL
of	NULL
Ly-49	NULL
promoters	NULL
by	NULL
TCF	NULL
site	NULL
I	NULL
NK	NULL
cells	NULL
expressing	NULL
certain	NULL
Ly-49	NULL
receptors	NULL
were	NULL
overrepresented	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
TCP-1	NULL
can	NULL
inhibit	NULL
Ly-49	NULL
acquisition	NULL
.	NULL

Because	NULL
the	NULL
Ly-49i	NULL
promoter	NULL
contains	NULL
a	NULL
single	NULL
consensus	NULL
TCF	NULL
site	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
TCE-1	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
was	NULL
inhibitory	NULL
.	NULL

To	NULL
address	NULL
this	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
a	NULL
modified	NULL
Ly-49a	NULL
promoter	NULL
,	NULL
in	NULL
which	NULL
the	NULL
20	NULL
bp	NULL
surrounding	NULL
TCF	NULL
site	NULL
II	NULL
were	NULL
deleted	NULL
and	NULL
that	NULL
had	NULL
retained	NULL
residual	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Reporter	NULL
gene	NULL
activation	NULL
by	NULL
this	NULL
construct	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
corresponding	NULL
construct	NULL
in	NULL
which	NULL
TCF	NULL
site	NULL
I	NULL
was	NULL
mutated	NULL
.	NULL

Control	NULL
experiments	NULL
using	NULL
EMSA	NULL
assays	NULL
ensured	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
TCF	NULL
site	NULL
I	NULL
abrogated	NULL
the	NULL
binding	NULL
of	NULL
rTCF-1	NULL
(	NULL
22	NULL
)	NULL
or	NULL
nuclear	NULL
extract	NULL
from	NULL
EL-4	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
construct	NULL
with	NULL
the	NULL
mutant	NULL
TCF	NULL
site	NULL
I	NULL
displayed	NULL
significantly	NULL
higher	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
EL-4	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
construct	NULL
with	NULL
a	NULL
wild-type	NULL
TCF	NULL
site	NULL
I	NULL
(	NULL
>	NULL
2-fold	NULL
increase	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
inhibition	NULL
by	NULL
TCF	NULL
site	NULL
I	NULL
was	NULL
true	NULL
for	NULL
natural	NULL
Ly-49	NULL
promoters	NULL
,	NULL
the	NULL
respective	NULL
site	NULL
was	NULL
also	NULL
mutated	NULL
in	NULL
the	NULL
Ly-49f	NULL
and	NULL
Ly-49i	NULL
promoters	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
TCF	NULL
site	NULL
I	NULL
mutant	NULL
Ly-49f	NULL
promoter	NULL
was	NULL
significantly	NULL
more	NULL
effective	NULL
in	NULL
reporter	NULL
gene	NULL
assays	NULL
than	NULL
its	NULL
wild-type	NULL
counterpart	NULL
(	NULL
~4-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Ly-49i	NULL
activity	NULL
was	NULL
not	NULL
increased	NULL
upon	NULL
the	NULL
elimination	NULL
of	NULL
TCF	NULL
site	NULL
I	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
Ly-49i	NULL
activity	NULL
(	NULL
of	NULL
129/	NULL
]	NULL
origin	NULL
)	NULL
may	NULL
be	NULL
repressed	NULL
in	NULL
EL-4	NULL
cells	NULL
by	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
Psfl	NULL
site	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
thus	NULL
provide	NULL
evidence	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF	NULL
II	NULL
,	NULL
TCF	NULL
site	NULL
I	NULL
can	NULL
negatively	NULL
influence	NULL
Ly-49	NULL
promoter	NULL
function	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
functional	NULL
studies	NULL
using	NULL
EL-4	NULL
cells	NULL
revealed	NULL
the	NULL
potential	NULL
of	NULL
two	NULL
cis-acting	NULL
elements	NULL
in	NULL
proximal	NULL
Ly-49	NULL
promoters	NULL
,	NULL
TCF	NULL
sites	NULL
II	NULL
and	NULL
I	NULL
,	NULL
to	NULL
influence	NULL
promoter	NULL
function	NULL
in	NULL
a	NULL
positive	NULL
or	NULL
a	NULL
negative	NULL
fashion	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
extension	NULL
,	NULL
they	NULL
may	NULL
help	NULL
to	NULL
explain	NULL
why	NULL
TCE-1	NULL
deficiency	NULL
can	NULL
influence	NULL
Ly-49	NULL
receptor	NULL
acquisition	NULL
in	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
ways	NULL
.	NULL

Discussion	NULL
We	NULL
show	NULL
in	NULL
this	NULL
study	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
expres-sion	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
TCE-1	NULL
results	NULL
in	NULL
contracted	NULL
(	NULL
Ly-49A	NULL
and	NULL
Ly-49D	NULL
)	NULL
,	NULL
expanded	NULL
(	NULL
Ly-49I	NULL
and	NULL
Ly-49G	NULL
)	NULL
,	NULL
or	NULL
unaltered	NULL
(	NULL
Ly-49C	NULL
)	NULL
NK	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6186	NULL
TCF	NULL
X	NULL
P	NULL
HI	NULL
V	NULL
Ly49a	NULL
In	NULL
yon	NULL
,	NULL
bul	NULL
LO	NULL
)	NULL
el	NULL
Ly49a	NULL
HUE	NULL
I	NULL
\n	NULL
on	NULL
mme	NULL
amman	NULL
Ly49a	NULL
del	NULL
II	NULL
RAF—lqz-DO—l	NULL
Ly49a	NULL
del	NULL
II	NULL
mut	NULL
1	NULL
Ly49f	NULL
mﬂ—	NULL
Ly49f	NULL
mut	NULL
I	NULL
-	NULL
=-=_	NULL
--	NULL
--	NULL
=	NULL
--	NULL
--	NULL
-Ly49i	NULL
q—v-D—	NULL
Ly49i	NULL
mut	NULL
|	NULL
-	NULL
=n	NULL
--	NULL
n	NULL
m	NULL
0	NULL
5	NULL
Fold	NULL
specific	NULL
activation	NULL
10	NULL
15	NULL
20	NULL
25	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Regulation	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
by	NULL
TCF	NULL
site	NULL
I.	NULL
TCF	NULL
site	NULL
I	NULL
was	NULL
mutated	NULL
in	NULL
the	NULL
Ly-49a	NULL
,	NULL
Ly-49f	NULL
,	NULL
and	NULL
Ly-49i	NULL
promoters	NULL
.	NULL

It	NULL
was	NULL
also	NULL
mutated	NULL
in	NULL
the	NULL
Ly-49a	NULL
construct	NULL
from	NULL
which	NULL
TCF	NULL
site	NULL
II	NULL
has	NULL
been	NULL
deleted	NULL
.	NULL

Rectangles	NULL
indicate	NULL
the	NULL
location	NULL
of	NULL
consensus	NULL
TCF	NULL
sites	NULL
,	NULL
circles	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
putative	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
thin	NULL
line	NULL
bridging	NULL
gaps	NULL
indicates	NULL
deletions	NULL
.	NULL

The	NULL
resulting	NULL
luciferase	NULL
reporter	NULL
gene	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
EL-4	NULL
.	NULL

Specific	NULL
reporter	NULL
gene	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
a	NULL
promoter-less	NULL
luciferase	NULL
construct	NULL
.	NULL

Data	NULL
indicate	NULL
mean	NULL
of	NULL
fold-specific	NULL
induction	NULL
(	NULL
+*SD	NULL
)	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

cell	NULL
subsets	NULL
expressing	NULL
Ly-49	NULL
receptors	NULL
.	NULL

Additional	NULL
experiments	NULL
suggest	NULL
that	NULL
these	NULL
effects	NULL
are	NULL
unrelated	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
Ly-49A	NULL
protein	NULL
or	NULL
the	NULL
failure	NULL
to	NULL
express	NULL
the	NULL
endogenous	NULL
Ly-49a	NULL
locus	NULL
.	NULL

The	NULL
failure	NULL
to	NULL
acquire	NULL
Ly-49A	NULL
is	NULL
indeed	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
TCF-1	NULL
in	NULL
the	NULL
NK	NULL
cells	NULL
themselves	NULL
,	NULL
and	NULL
not	NULL
environment	NULL
in	NULL
which	NULL
these	NULL
develop	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
TCF-1-dependent	NULL
effects	NULL
on	NULL
Ly-49	NULL
usage	NULL
are	NULL
not	NULL
readily	NULL
mirrored	NULL
by	NULL
the	NULL
gene	NULL
order	NULL
in	NULL
the	NULL
Ly-49	NULL
cluster	NULL
(	NULL
Ly-49d-//-	NULL
Ly-49i-	NULL
Ly-49g-//-Ly-49c-	NULL
Ly-49a	NULL
)	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
)	NULL
.	NULL

They	NULL
seem	NULL
also	NULL
unrelated	NULL
to	NULL
the	NULL
presumed	NULL
order	NULL
in	NULL
which	NULL
these	NULL
receptors	NULL
are	NULL
acquired	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
(	NULL
A-G-	NULL
>	NULL
C/I-D	NULL
)	NULL
(	NULL
5	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
TCP-1	NULL
deficiency	NULL
results	NULL
in	NULL
a	NULL
cell	NULL
autonomous	NULL
defect	NULL
,	NULL
which	NULL
independently	NULL
perturbs	NULL
the	NULL
acquisition	NULL
of	NULL
multiple	NULL
Ly-49	NULL
receptors	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
TCF-1	NULL
dependence	NULL
of	NULL
Ly-49A	NULL
acquisition	NULL
in	NULL
vivo	NULL
,	NULL
together	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
consensus	NULL
TCF	NULL
sites	NULL
in	NULL
the	NULL
proximal	NULL
Ly-49a	NULL
promoter	NULL
,	NULL
which	NULL
bind	NULL
TCF-1	NULL
and	NULL
regulate	NULL
promoter	NULL
function	NULL
(	NULL
22	NULL
)	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
and	NULL
analyzed	NULL
additional	NULL
Ly-49	NULL
promoters	NULL
.	NULL

Indeed	NULL
,	NULL
inhibitory	NULL
Ly-49	NULL
receptors	NULL
that	NULL
displayed	NULL
an	NULL
altered	NULL
usage	NULL
in	NULL
TCF-1-deficient	NULL
mice	NULL
contained	NULL
at	NULL
least	NULL
one	NULL
TCF	NULL
binding	NULL
site	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
no	NULL
consensus	NULL
TCF	NULL
binding	NULL
site	NULL
was	NULL
present	NULL
in	NULL
the	NULL
proximal	NULL
Ly-49d	NULL
promoter	NULL
,	NULL
while	NULL
Ly-49D	NULL
usage	NULL
was	NULL
clearly	NULL
reduced	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
in	NULL
vivo	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
direct	NULL
action	NULL
of	NULL
TCF-1	NULL
on	NULL
proximal	NULL
promoters	NULL
,	NULL
as	NULL
suggested	NULL
for	NULL
Ly-49a	NULL
,	NULL
we	NULL
have	NULL
to	NULL
consider	NULL
the	NULL
possibility	NULL
that	NULL
TCF-1-dependent	NULL
effects	NULL
may	NULL
also	NULL
be	NULL
exerted	NULL
by	NULL
TCF-1	NULL
binding	NULL
to	NULL
cis-acting	NULL
elements	NULL
that	NULL
are	NULL
located	NULL
elsewhere	NULL
in	NULL
the	NULL
gene	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
TCF-1-dependent	NULL
effects	NULL
may	NULL
be	NULL
indirect	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
based	NULL
on	NULL
deregulated	NULL
expression	NULL
of	NULL
additional	NULL
transcription	NULL
factors	NULL
.	NULL

There	NULL
is	NULL
indeed	NULL
some	NULL
evidence	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
activating	NULL
Ly-49	NULL
receptors	NULL
may	NULL
differ	NULL
from	NULL
their	NULL
inhibitory	NULL
counterparts	NULL
.	NULL

Activating	NULL
Ly-49	NULL
receptors	NULL
are	NULL
not	NULL
expressed	NULL
in	NULL
NK	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
their	NULL
coexpression	NULL
deviates	NULL
from	NULL
the	NULL
predicted	NULL
value	NULL
that	NULL
indicates	NULL
independent	NULL
expression	NULL
(	NULL
5	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Whatever	NULL
the	NULL
precise	NULL
TCF-1	NULL
target	NULL
,	NULL
Ly-49	NULL
promoters	NULL
seem	NULL
to	NULL
control	NULL
important	NULL
aspects	NULL
of	NULL
Ly-49	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
strictly	NULL
correlated	NULL
with	NULL
endogenous	NULL
Ly-49A	NULL
usage	NULL
in	NULL
cell	NULL
lines	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Ly-49A	NULL
and	NULL
G	NULL
by	NULL
EL-4	NULL
cells	NULL
correlated	NULL
with	NULL
the	NULL
efficient	NULL
activity	NULL
of	NULL
the	NULL
respective	NULL
(	NULL
but	NULL
not	NULL
other	NULL
)	NULL
promoters	NULL
.	NULL

The	NULL
promoter	NULL
may	NULL
thus	NULL
be	NULL
important	NULL
to	NULL
control	NULL
tissue	NULL
specificity	NULL
of	NULL
Ly-49	NULL
expression	NULL
.	NULL

The	NULL
functional	NULL
studies	NULL
also	NULL
revealed	NULL
an	NULL
important	NULL
role	NULL
of	NULL
TCF	NULL
binding	NULL
sites	NULL
TCF-1	NULL
DEPENDENCE	NULL
OF	NULL
THE	NULL
Ly-49	NULL
RECEPTOR	NULL
REPERTOIRE	NULL
to	NULL
regulate	NULL
Ly-49	NULL
promoter	NULL
function	NULL
.	NULL

Site	NULL
II	NULL
was	NULL
required	NULL
for	NULL
efficient	NULL
function	NULL
of	NULL
proximal	NULL
Ly-49	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
this	NULL
site	NULL
was	NULL
absent	NULL
in	NULL
three	NULL
Ly-49	NULL
promoters	NULL
due	NULL
to	NULL
a	NULL
20-bp	NULL
deletion	NULL
.	NULL

This	NULL
deletion	NULL
removes	NULL
exactly	NULL
two	NULL
turns	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
,	NULL
leaving	NULL
trans-acting	NULL
factors	NULL
bound	NULL
adjacent	NULL
to	NULL
this	NULL
site	NULL
in	NULL
phase	NULL
,	NULL
yet	NULL
bringing	NULL
them	NULL
into	NULL
proximity	NULL
.	NULL

Interestingly	NULL
,	NULL
that	NULL
is	NULL
the	NULL
proposed	NULL
role	NULL
of	NULL
TCE/LEF	NULL
factors	NULL
in	NULL
the	NULL
TCRa	NULL
enhancer	NULL
:	NULL
DNA	NULL
binding	NULL
induces	NULL
a	NULL
bend	NULL
in	NULL
the	NULL
DNA	NULL
helix	NULL
,	NULL
which	NULL
brings	NULL
proteins	NULL
bound	NULL
to	NULL
sites	NULL
surrounding	NULL
TCF/LEF	NULL
sites	NULL
into	NULL
proximity	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
TCF	NULL
II	NULL
due	NULL
to	NULL
a	NULL
20-bp	NULL
deletion	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
remaining	NULL
TCF	NULL
site	NULL
I	NULL
repressed	NULL
promoter	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
TCF	NULL
II	NULL
seemed	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
repressing	NULL
function	NULL
of	NULL
TCF	NULL
I	NULL
.	NULL

The	NULL
latter	NULL
site	NULL
failed	NULL
to	NULL
repress	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TCF	NULL
II	NULL
or	NULL
in	NULL
its	NULL
absence	NULL
due	NULL
to	NULL
the	NULL
introduction	NULL
of	NULL
point	NULL
mutations	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
that	NULL
distinct	NULL
TCF	NULL
sites	NULL
can	NULL
modulate	NULL
promoter	NULL
function	NULL
in	NULL
a	NULL
positive	NULL
or	NULL
negative	NULL
fashion	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
TCF	NULL
sites	NULL
is	NULL
influenced	NULL
by	NULL
their	NULL
context	NULL
.	NULL

In	NULL
extension	NULL
,	NULL
the	NULL
data	NULL
help	NULL
to	NULL
explain	NULL
why	NULL
TCE-1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
acquisition	NULL
of	NULL
certain	NULL
Ly-49	NULL
receptors	NULL
,	NULL
while	NULL
it	NULL
suppresses	NULL
others	NULL
.	NULL

Although	NULL
these	NULL
findings	NULL
illustrate	NULL
the	NULL
principle	NULL
,	NULL
there	NULL
remain	NULL
differences	NULL
between	NULL
the	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
data	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Perhaps	NULL
these	NULL
arise	NULL
because	NULL
transient	NULL
transfections	NULL
reveal	NULL
the	NULL
architectural	NULL
function	NULL
of	NULL
TCE-1	NULL
.	NULL

The	NULL
role	NULL
of	NULL
TCF-1	NULL
during	NULL
Ly-49	NULL
receptor	NULL
acquisition	NULL
may	NULL
be	NULL
to	NULL
make	NULL
chromatin	NULL
accessible	NULL
and	NULL
to	NULL
allow	NULL
additional	NULL
transcription	NULL
factors	NULL
to	NULL
bind	NULL
the	NULL
promoter	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
dual	NULL
role	NULL
of	NULL
TCFs	NULL
has	NULL
become	NULL
apparent	NULL
in	NULL
cell	NULL
fate	NULL
determination	NULL
during	NULL
Xenopus	NULL
and	NULL
Drosophila	NULL
development	NULL
.	NULL

Target	NULL
gene	NULL
induction	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
wnt-dependent	NULL
association	NULL
of	NULL
TCFs	NULL
with	NULL
B-catenin	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
wnt	NULL
signals	NULL
and	NULL
consequently	NULL
intracellular	NULL
free	NULL
B-catenin	NULL
,	NULL
target	NULL
gene	NULL
expression	NULL
is	NULL
repressed	NULL
via	NULL
the	NULL
interaction	NULL
of	NULL
TCFs	NULL
with	NULL
Groucho-related	NULL
proteins	NULL
(	NULL
27	NULL
)	NULL
,	NULL
CBP	NULL
(	NULL
40	NULL
)	NULL
,	NULL
or	NULL
NEMO-like	NULL
kinase	NULL
(	NULL
41	NULL
)	NULL
.	NULL

It	NULL
will	NULL
thus	NULL
be	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
Ly-49	NULL
receptor	NULL
acquisition	NULL
is	NULL
influenced	NULL
by	NULL
TCF	NULL
cofactors	NULL
.	NULL

Like	NULL
Ly-49a	NULL
,	NULL
the	NULL
Ly-49g	NULL
promoter	NULL
contained	NULL
two	NULL
TCF	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
Ly-49A	NULL
,	NULL
Ly-49G	NULL
usage	NULL
was	NULL
increased	NULL
in	NULL
TCE-1-deficient	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Because	NULL
preliminary	NULL
experiments	NULL
indicate	NULL
that	NULL
Ly-49g	NULL
promoter	NULL
activity	NULL
is	NULL
also	NULL
dependent	NULL
in	NULL
part	NULL
on	NULL
TCF	NULL
site	NULL
II	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TCF-1	NULL
,	NULL
Ly-49G	NULL
acquisition	NULL
is	NULL
ensured	NULL
by	NULL
another	NULL
trans-acting	NULL
factor	NULL
that	NULL
can	NULL
bind	NULL
TCF	NULL
sites	NULL
,	NULL
such	NULL
as	NULL
LEF-1	NULL
.	NULL

Indeed	NULL
,	NULL
TCF-1	NULL
and	NULL
LEF-1	NULL
have	NULL
identical	NULL
DNA-binding	NULL
specificity	NULL
and	NULL
LEF-1	NULL
can	NULL
substitute	NULL
for	NULL
TCF-1	NULL
to	NULL
mediate	NULL
TCRa	NULL
enhancer	NULL
function	NULL
(	NULL
42	NULL
)	NULL
.	NULL

We	NULL
are	NULL
thus	NULL
currently	NULL
testing	NULL
whether	NULL
in	NULL
addition	NULL
to	NULL
TCF-1	NULL
,	NULL
LEF-1	NULL
is	NULL
playing	NULL
a	NULL
role	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
Ly-49	NULL
receptor	NULL
repertoire	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
one	NULL
of	NULL
the	NULL
differences	NULL
between	NULL
the	NULL
Ly-49a	NULL
and	NULL
Ly-49g	NULL
promoter	NULL
sequences	NULL
may	NULL
affect	NULL
ATF-2	NULL
binding	NULL
to	NULL
the	NULL
Ly-49g	NULL
promoter	NULL
.	NULL

In	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
,	NULL
ATF-2	NULL
binds	NULL
a	NULL
nonconsensus	NULL
cAMP-responsive	NULL
element	NULL
and	NULL
regulates	NULL
promoter	NULL
activity	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
TCF	NULL
site	NULL
I	NULL
and	NULL
the	NULL
ATF-2	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
Ly-49a	NULL
promoter	NULL
overlap	NULL
partially	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
ATF-2	NULL
binding	NULL
can	NULL
prevent	NULL
TCF-1	NULL
binding	NULL
to	NULL
the	NULL
inhibitory	NULL
site	NULL
I	NULL
in	NULL
the	NULL
Ly-49a	NULL
,	NULL
but	NULL
not	NULL
the	NULL
Ly-49g	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
way	NULL
,	NULL
TCE-1	NULL
might	NULL
be	NULL
able	NULL
to	NULL
depress	NULL
Ly-49G	NULL
,	NULL
but	NULL
not	NULL
Ly-49A	NULL
usage	NULL
.	NULL

Promoter	NULL
diversity	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
Ly-49	NULL
receptor	NULL
repertoire	NULL
When	NULL
considering	NULL
only	NULL
the	NULL
presence/absence	NULL
of	NULL
the	NULL
two	NULL
consensus	NULL
TCFE-binding	NULL
motifs	NULL
,	NULL
we	NULL
find	NULL
four	NULL
different	NULL
configurations	NULL
among	NULL
the	NULL
six	NULL
Ly-49	NULL
promoters	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
schematic	NULL
representation	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
demonstrating	NULL
considerable	NULL
heterogeneity	NULL
among	NULL
Ly-49	NULL
promoters	NULL
.	NULL

The	NULL
implication	NULL
of	NULL
TCE-1	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
additional	NULL
factors	NULL
for	NULL
Ly-49	NULL
promoter	NULL
function	NULL
and/or	NULL
the	NULL
developmentally	NULL
regulated	NULL
Ly-49	NULL
acquisition	NULL
process	NULL
.	NULL

As	NULL
pointed	NULL
out	NULL
above	NULL
,	NULL
TCF-1	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
has	NULL
no	NULL
transactivation	NULL
capacity	NULL
by	NULL
itself	NULL
.	NULL

In	NULL
the	NULL
minimal	NULL
TCRa	NULL
enhancer	NULL
,	NULL
TCF-1	NULL
and	NULL
its	NULL
homologue	NULL
LEF-1	NULL
function	NULL
in	NULL
collaboration	NULL
with	NULL
additional	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
ets	NULL
,	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
,	NULL
and	NULL
core	NULL
binding	NULL
factor	NULL
families	NULL
(	NULL
28	NULL
,	NULL
30	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Ly-49	NULL
promoter	NULL
sequences	NULL
(	NULL
and	NULL
relevant	NULL
elements	NULL
therein	NULL
)	NULL
display	NULL
diversity	NULL
provides	NULL
circumstantial	NULL
evidence	NULL
that	NULL
differential	NULL
Ly-49	NULL
receptor	NULL
expression	NULL
in	NULL
NK	NULL
cells	NULL
may	NULL
be	NULL
mediated	NULL
via	NULL
the	NULL
differential	NULL
yet	NULL
partially	NULL
conserved	NULL
presence	NULL
and	NULL
occupancy	NULL
of	NULL
protein-binding	NULL
sites	NULL
in	NULL
Ly-49	NULL
promoters	NULL
.	NULL

Therefore	NULL
,	NULL
distinct	NULL
Ly-49	NULL
genes	NULL
may	NULL
be	NULL
controlled	NULL
by	NULL
partially	NULL
overlapping	NULL
sets	NULL
of	NULL
DNA-binding	NULL
factors	NULL
.	NULL

Ly-49	NULL
receptor	NULL
acquisition	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
may	NULL
occur	NULL
when	NULL
an	NULL
appropriate	NULL
factor	NULL
complex	NULL
forms	NULL
at	NULL
a	NULL
given	NULL
promoter	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
would	NULL
be	NULL
required	NULL
to	NULL
initiate	NULL
Ly-49	NULL
receptor	NULL
expression	NULL
in	NULL
an	NULL
all	NULL
or	NULL
none	NULL
fashion	NULL
.	NULL

That	NULL
event	NULL
may	NULL
occur	NULL
with	NULL
a	NULL
low	NULL
probability	NULL
,	NULL
accounting	NULL
for	NULL
the	NULL
relatively	NULL
low	NULL
rate	NULL
of	NULL
Ly-49	NULL
receptor	NULL
acquisition	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
TCF-1	NULL
influences	NULL
positively	NULL
or	NULL
negatively	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
putative	NULL
complex	NULL
at	NULL
Ly-49	NULL
promoters	NULL
.	NULL

Note	NULL
added	NULL
in	NULL
proof	NULL
.	NULL

The	NULL
sequence	NULL
assigned	NULL
here	NULL
to	NULL
Ly-49i	NULL
corresponds	NULL
to	NULL
Ly-49j	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
Ly-49i	NULL
sequence	NULL
has	NULL
the	NULL
same	NULL
configuration	NULL
of	NULL
TCE/LEF	NULL
sites	NULL
as	NULL
Ly-49j	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
H.	NULL
Clevers	NULL
for	NULL
providing	NULL
TCF-1-deficient	NULL
mice	NULL
;	NULL
J.	NULL
Roland	NULL
and	NULL
S.	NULL
Lemieux	NULL
for	NULL
providing	NULL
mAbs	NULL
;	NULL
and	NULL
J.-C.	NULL
Cerottini	NULL
,	NULL
V.	NULL
Ioannidis	NULL
,	NULL
F.	NULL
Radtke	NULL
,	NULL
and	NULL
J.	NULL
Zimmer	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Smith	NULL
,	NULL
H.	NULL
R.	NULL
C.	NULL
,	NULL
F.	NULL
M.	NULL
Karlhofer	NULL
,	NULL
and	NULL
W.	NULL
M.	NULL
Yokoyama	NULL
.	NULL

1994	NULL
.	NULL

Ly-49	NULL
multigene	NULL
family	NULL
expressed	NULL
by	NULL
IL-2-activated	NULL
NK	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:1068	NULL
.	NULL

2	NULL
.	NULL

Wong	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
D.	NULL
Freeman	NULL
,	NULL
C.	NULL
Kelleher	NULL
,	NULL
D.	NULL
Mager	NULL
,	NULL
and	NULL
F.	NULL
Takei	NULL
.	NULL

1991	NULL
.	NULL

Ly-49	NULL
multigene	NULL
family	NULL
:	NULL
new	NULL
members	NULL
of	NULL
a	NULL
superfamily	NULL
of	NULL
type	NULL
II	NULL
membrane	NULL
proteins	NULL
with	NULL
lectin-like	NULL
domains	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:1417	NULL
.	NULL

3	NULL
.	NULL

Hanke	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Takizawa	NULL
,	NULL
C.	NULL
W.	NULL
McMahon	NULL
,	NULL
D.	NULL
H.	NULL
Busch	NULL
,	NULL
E.	NULL
G.	NULL
Pamer	NULL
,	NULL
J.	NULL
D.	NULL
Miller	NULL
,	NULL
J.	NULL
D.	NULL
Altman	NULL
,	NULL
Y.	NULL
Liu	NULL
,	NULL
D.	NULL
Cado	NULL
,	NULL
F.	NULL
A.	NULL
Lemonnier	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1999	NULL
.	NULL

Direct	NULL
assessment	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
binding	NULL
by	NULL
seven	NULL
Ly49	NULL
inhibitory	NULL
NK	NULL
cell	NULL
receptors	NULL
.	NULL

Immunity	NULL
11:67	NULL
.	NULL

4	NULL
.	NULL

Nakamura	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
P.	NULL
A.	NULL
Linnemeyer	NULL
,	NULL
E.	NULL
C.	NULL
Niemi	NULL
,	NULL
L.	NULL
H.	NULL
Mason	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
J.	NULL
C.	NULL
Ryan	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Seaman	NULL
.	NULL

1999	NULL
.	NULL

Mouse	NULL
Ly49D	NULL
recognizes	NULL
H-2D°	NULL
and	NULL
activates	NULL
natural	NULL
killer	NULL
cell	NULL
cytotoxicity	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

189:493	NULL
.	NULL

5	NULL
.	NULL

Smith	NULL
,	NULL
H.	NULL
R.	NULL
C.	NULL
,	NULL
H.	NULL
H.	NULL
Chuang	NULL
,	NULL
L.	NULL
L.	NULL
Wang	NULL
,	NULL
M.	NULL
Salcedo	NULL
,	NULL
J.	NULL
W.	NULL
Heusel	NULL
,	NULL
and	NULL
W.	NULL
M.	NULL
Yokoyama	NULL
.	NULL

2000	NULL
.	NULL

Nonstochastic	NULL
coexpression	NULL
of	NULL
activation	NULL
receptors	NULL
on	NULL
murine	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

191:1341	NULL
.	NULL

6	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
H.	NULL
Bakker	NULL
,	NULL
J.	NULL
H.	NULL
Phillips	NULL
,	NULL
and	NULL
L.	NULL
L.	NULL
Lanier	NULL
.	NULL

1998	NULL
.	NULL

Ly49-D	NULL
and	NULL
Ly49-H	NULL
associate	NULL
with	NULL
mouse	NULL
DAP12	NULL
and	NULL
form	NULL
activating	NULL
receptors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:7	NULL
.	NULL

7	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
S.	NULL
Fulmek	NULL
,	NULL
K.	NULL
Matsumoto	NULL
,	NULL
R.	NULL
Cho	NULL
,	NULL
P.	NULL
A.	NULL
Lyons	NULL
,	NULL
E.	NULL
R.	NULL
Levy	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Scalzo	NULL
,	NULL
and	NULL
W.	NULL
M.	NULL
Yokoyama	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
2-Mb	NULL
YAC	NULL
contig	NULL
and	NULL
physical	NULL
map	NULL
of	NULL
the	NULL
natural	NULL
killer	NULL
gene	NULL
complex	NULL
on	NULL
mouse	NULL
chromosome	NULL
6	NULL
.	NULL

Genomics	NULL
42:16	NULL
.	NULL

8	NULL
.	NULL

McQueen	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
J.	NULL
D.	NULL
Freeman	NULL
,	NULL
F.	NULL
Takei	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mager	NULL
.	NULL

1998	NULL
.	NULL

Localization	NULL
of	NULL
five	NULL
new	NULL
Ly49	NULL
genes	NULL
,	NULL
including	NULL
three	NULL
closely	NULL
related	NULL
to	NULL
Ly49c	NULL
.	NULL

Immunogenetics	NULL
48:174	NULL
.	NULL

9	NULL
.	NULL

Coles	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
C.	NULL
W.	NULL
McMahon	NULL
,	NULL
H.	NULL
Takizawa	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

2000	NULL
.	NULL

Memory	NULL
CD8	NULL
T	NULL
lymphocytes	NULL
express	NULL
inhibitory	NULL
MHC-specific	NULL
Ly49	NULL
receptors	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:236	NULL
.	NULL

10	NULL
.	NULL

Kubota	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Kubota	NULL
,	NULL
S.	NULL
Lohwasser	NULL
,	NULL
D.	NULL
L.	NULL
Mager	NULL
,	NULL
and	NULL
F.	NULL
Takei	NULL
.	NULL

1999	NULL
.	NULL

Diversity	NULL
of	NULL
NK	NULL
cell	NULL
receptor	NULL
repertoire	NULL
in	NULL
adult	NULL
and	NULL
neonatal	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163:212	NULL
.	NULL

11	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
Roland	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1995	NULL
.	NULL

Allelic	NULL
exclusion	NULL
of	NULL
Ly49	NULL
family	NULL
genes	NULL
encoding	NULL
class	NULL
-MHC-specific	NULL
receptors	NULL
on	NULL
NK	NULL
cells	NULL
.	NULL

Nature	NULL
376:355	NULL
.	NULL

12	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
B.	NULL
Kunz	NULL
.	NULL

1998	NULL
.	NULL

An	NULL
allele-specific	NULL
,	NULL
stochastic	NULL
gene	NULL
expression	NULL
process	NULL
controls	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
Ly49	NULL
family	NULL
genes	NULL
and	NULL
generates	NULL
a	NULL
di-verse	NULL
,	NULL
MHC-specific	NULL
NK	NULL
cell	NULL
receptor	NULL
repertoire	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:2407	NULL
.	NULL

13	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
R.	NULL
Dorfman	NULL
,	NULL
M.-F.	NULL
Wu	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1996	NULL
.	NULL

Major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
dependent	NULL
skewing	NULL
of	NULL
the	NULL
natural	NULL
killer	NULL
cell	NULL
Ly49	NULL
receptor	NULL
repertoire	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:2286	NULL
.	NULL

14	NULL
.	NULL

Raulet	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
W.	NULL
Held	NULL
,	NULL
I.	NULL
Correa	NULL
,	NULL
J.	NULL
Dorfman	NULL
,	NULL
M.-F.	NULL
Wu	NULL
,	NULL
and	NULL
L.	NULL
Corral	NULL
.	NULL

1997	NULL
.	NULL

Specificity	NULL
,	NULL
tolerance	NULL
and	NULL
developmental	NULL
regulation	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
defined	NULL
by	NULL
expression	NULL
of	NULL
class	NULL
I	NULL
specific	NULL
Ly49	NULL
receptors	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

155:41	NULL
.	NULL

15	NULL
.	NULL

Williams	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
T.	NULL
A.	NULL
Moore	NULL
,	NULL
J.	NULL
D.	NULL
Schatzle	NULL
,	NULL
I.	NULL
J.	NULL
Puzanov	NULL
,	NULL
P.	NULL
A.	NULL
Sivakumar	NULL
,	NULL
A.	NULL
Zlotnik	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
and	NULL
V.	NULL
Kumar	NULL
.	NULL

1997	NULL
.	NULL

Generation	NULL
of	NULL
lytic	NULL
natural	NULL
killer	NULL
1.1	NULL
%	NULL
,	NULL
Ly49~	NULL
cells	NULL
from	NULL
multipotent	NULL
murine	NULL
bone	NULL
marrow	NULL
progenitors	NULL
in	NULL
a	NULL
stroma-free	NULL
culture	NULL
:	NULL
definition	NULL
of	NULL
cytokine	NULL
requirements	NULL
and	NULL
developmental	NULL
intermedi-ates	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1609	NULL
.	NULL

16	NULL
.	NULL

Williams	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
J.	NULL
Klem	NULL
,	NULL
I	NULL
J.	NULL
Puzanov	NULL
,	NULL
P.	NULL
V.	NULL
Sivakumar	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
and	NULL
V.	NULL
Kumar	NULL
.	NULL

1999	NULL
.	NULL

Differentiation	NULL
of	NULL
NK1.1*	NULL
,	NULL
Ly49*	NULL
NK	NULL
cells	NULL
from	NULL
fit3*	NULL
multipotent	NULL
progenitor	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163:2648	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

6187	NULL
Dorfman	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1998	NULL
.	NULL

Acquisition	NULL
of	NULL
Ly49	NULL
receptor	NULL
expression	NULL
by	NULL
developing	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:609	NULL
.	NULL

Roth	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Carlyle	NULL
,	NULL
H.	NULL
Takizawa	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

2000	NULL
.	NULL

Clonal	NULL
acquisition	NULL
of	NULL
inhibitory	NULL
Ly49	NULL
receptors	NULL
on	NULL
developing	NULL
NK	NULL
cells	NULL
is	NULL
successively	NULL
restricted	NULL
and	NULL
regulated	NULL
by	NULL
stromal	NULL
class	NULL
I	NULL
MHC	NULL
.	NULL

Immunity	NULL
13:143	NULL
.	NULL

Williams	NULL
,	NULL
N.	NULL
s.	NULL
,	NULL
A.	NULL
Kubota	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
and	NULL
F.	NULL
Takei	NULL
.	NULL

2000	NULL
.	NULL

Clonal	NULL
analysis	NULL
of	NULL
NK	NULL
cell	NULL
development	NULL
from	NULL
bone	NULL
marrow	NULL
progenitors	NULL
in	NULL
vitro	NULL
:	NULL
orderly	NULL
acquisition	NULL
of	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:2074	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1997	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Ly49A	NULL
gene	NULL
in	NULL
murine	NULL
natural	NULL
killer	NULL
cell	NULL
clones	NULL
is	NULL
predominantly	NULL
but	NULL
not	NULL
exclusively	NULL
mono-allelic	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2876	NULL
.	NULL

MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
R.	NULL
K.	NULL
Lees	NULL
,	NULL
and	NULL
W.	NULL
Held	NULL
.	NULL

1998	NULL
.	NULL

Developmentally	NULL
regulated	NULL
extinction	NULL
of	NULL
Ly-49	NULL
receptor	NULL
expression	NULL
permits	NULL
maturation	NULL
and	NULL
selection	NULL
of	NULL
NKI1-1*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:2109	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
B.	NULL
Kunz	NULL
,	NULL
B.	NULL
Lowin-Kropf	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1999	NULL
.	NULL

Clonal	NULL
acquisition	NULL
of	NULL
the	NULL
Ly49A	NULL
NK	NULL
cell	NULL
receptor	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
frans	NULL
acting	NULL
factor	NULL
TCF-1	NULL
.	NULL

Immunity	NULL
11:433	NULL
.	NULL

Behrens	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
P.	NULL
von	NULL
Kries	NULL
,	NULL
M.	NULL
Kiihl	NULL
,	NULL
L.	NULL
Brubm	NULL
,	NULL
D.	NULL
Wedlich	NULL
,	NULL
R.	NULL
Grosschedl	NULL
,	NULL
and	NULL
W.	NULL
Birchmeier	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
interaction	NULL
of	NULL
B-catenin	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
LEF-1	NULL
.	NULL

Nature	NULL
382:638	NULL
.	NULL

Molenaar	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
J.	NULL
Peterson-Maduro	NULL
,	NULL
V.	NULL
Korinek	NULL
,	NULL
J.	NULL
Roose	NULL
,	NULL
O.	NULL
Desiree	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1996	NULL
.	NULL

XTecf-3	NULL
transcription	NULL
factor	NULL
mediates	NULL
B-catenin-induced	NULL
axis	NULL
formation	NULL
in	NULL
Xenopus	NULL
embryos	NULL
.	NULL

Cell	NULL
86	NULL
:	NULL
391	NULL
.	NULL

Brannon	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Gomperts	NULL
,	NULL
L.	NULL
Sumoy	NULL
,	NULL
R.	NULL
T.	NULL
Moon	NULL
,	NULL
and	NULL
D.	NULL
Kimelman	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
B-catenin/X-Tcf-3	NULL
complex	NULL
binds	NULL
to	NULL
the	NULL
siamois	NULL
promoter	NULL
to	NULL
regulate	NULL
dorsal	NULL
axis	NULL
specification	NULL
in	NULL
Xenopus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:2359	NULL
.	NULL

Riese	NULL
,	NULL
J.	NULL
,	NULL
X.	NULL
Yu	NULL
,	NULL
A.	NULL
Munnerlyn	NULL
,	NULL
S.	NULL
Eresh	NULL
,	NULL
S.-C.	NULL
Hsu	NULL
,	NULL
R.	NULL
and	NULL
M.	NULL
Bienz	NULL
.	NULL

1997	NULL
.	NULL

Lef-1	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
coordinating	NULL
signaling	NULL
inputs	NULL
from	NULL
wingless	NULL
and	NULL
decapentaplegic	NULL
.	NULL

Cell	NULL
88:777	NULL
.	NULL

Roose	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Molenaar	NULL
,	NULL
J.	NULL
Peterson	NULL
,	NULL
J.	NULL
Hurenkamp	NULL
,	NULL
H.	NULL
Brantjes	NULL
,	NULL
P.	NULL
Moerer	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
O.	NULL
Destrée	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Xenopus	NULL
Wnt	NULL
effector	NULL
XTcf-3	NULL
interacts	NULL
with	NULL
Groucho-related	NULL
transcriptional	NULL
repressors	NULL
.	NULL

Nature	NULL
395	NULL
;	NULL
608	NULL
.	NULL

Van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Gastrop	NULL
,	NULL
V.	NULL
Korinek	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1996	NULL
.	NULL

Extensive	NULL
alternative	NULL
splicing	NULL
and	NULL
dual	NULL
promoter	NULL
usage	NULL
generate	NULL
TCF-1	NULL
protein	NULL
isoforms	NULL
with	NULL
differential	NULL
transcription	NULL
control	NULL
properties	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:745	NULL
.	NULL

Hsu	NULL
,	NULL
S.-H.	NULL
,	NULL
J.	NULL
Galceran	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1998	NULL
.	NULL

Modulation	NULL
of	NULL
transcriptional	NULL
regulation	NULL
by	NULL
LEF-1	NULL
in	NULL
response	NULL
to	NULL
Want-1	NULL
signaling	NULL
and	NULL
association	NULL
with	NULL
B-cate-nin	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:4807	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Kingsley	NULL
,	NULL
J.	NULL
R.	NULL
Kirshner	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1995	NULL
.	NULL

Assembly	NULL
and	NULL
function	NULL
of	NULL
a	NULL
TCRa	NULL
enhancer	NULL
complex	NULL
is	NULL
dependent	NULL
on	NULL
LBF-l-induced	NULL
DNA	NULL
bending	NULL
and	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:995	NULL
.	NULL

Verbeck	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Izon	NULL
,	NULL
F.	NULL
Hofhuis	NULL
,	NULL
E.	NULL
Robanus-Maandag	NULL
,	NULL
H.	NULL
te	NULL
Ricle	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
H.	NULL
R.	NULL
MacDonald	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
HMG-box-containing	NULL
T-cell	NULL
factor	NULL
required	NULL
for	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

Nature	NULL
374:70	NULL
.	NULL

Held	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1997	NULL
.	NULL

Ly49A	NULL
transgenic	NULL
mice	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
major	NULL
histocompatibility	NULL
complex-dependent	NULL
education	NULL
process	NULL
in	NULL
natural	NULL
killer	NULL
cell	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:2079	NULL
.	NULL

Roland	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Cazenave	NULL
.	NULL

1992	NULL
.	NULL

Ly-49	NULL
antigen	NULL
defines	NULL
an	NULL
«	NULL
B	NULL
TCR	NULL
population	NULL
in	NULL
i-IEL	NULL
with	NULL
an	NULL
extrathymic	NULL
maturation	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

4:699	NULL
.	NULL

Gosslin	NULL
,	NULL
P.	NULL
,	NULL
Y.	NULL
Lusignana	NULL
,	NULL
J.	NULL
Brennan	NULL
,	NULL
F.	NULL
Takei	NULL
,	NULL
and	NULL
S.	NULL
Lemieux	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
NK2.1	NULL
receptor	NULL
is	NULL
encoded	NULL
by	NULL
Ly49C	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
MHC	NULL
class	NULL
I	NULL
alleles	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

9:533	NULL
.	NULL

Kubo	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Itoh	NULL
,	NULL
N.	NULL
Ishikawa	NULL
,	NULL
R.	NULL
Nagasawa	NULL
,	NULL
T.	NULL
Mitarai	NULL
,	NULL
and	NULL
N.	NULL
Maruyama	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
gene	NULL
encoding	NULL
mouse	NULL
lymphocyte	NULL
antigen	NULL
Ly-49	NULL
:	NULL
structural	NULL
analysis	NULL
and	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
.	NULL

Gene	NULL
136:329	NULL
.	NULL

Toomey	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
Shrestha	NULL
,	NULL
S.	NULL
A.	NULL
de	NULL
la	NULL
Rue	NULL
,	NULL
F.	NULL
Gayes	NULL
,	NULL
J.	NULL
H.	NULL
Robinson	NULL
,	NULL
Z.	NULL
M.	NULL
A.	NULL
Chrzanowska-Lightowlers	NULL
,	NULL
and	NULL
C.	NULL
Brooks	NULL
.	NULL

1998	NULL
.	NULL

MHC	NULL
class	NULL
I	NULL
expression	NULL
protects	NULL
target	NULL
cells	NULL
from	NULL
lysis	NULL
by	NULL
Ly49-deficient	NULL
fetal	NULL
NK	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:47	NULL
.	NULL

Gosslin	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
P.	NULL
Makrigiannis	NULL
,	NULL
R.	NULL
Nalewik	NULL
,	NULL
and	NULL
S.	NULL
K.	NULL
Anderson	NULL
.	NULL

2000	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
Ly49I	NULL
promoter	NULL
.	NULL

Immunogenetics	NULL
51:326	NULL
.	NULL

Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
R.	NULL
Winkler-Pickett	NULL
,	NULL
A.	NULL
T.	NULL
Mason	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Mason	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Ly49	NULL
family	NULL
:	NULL
regulation	NULL
of	NULL
cytotoxicity	NULL
and	NULL
cytokine	NULL
production	NULL
in	NULL
murine	NULL
CD3	NULL
*	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1158	NULL
.	NULL

Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
L.	NULL
Roberts	NULL
,	NULL
and	NULL
M.	NULL
Krangel	NULL
.	NULL

1998	NULL
.	NULL

Cooperation	NULL
among	NULL
multiple	NULL
transcription	NULL
factors	NULL
is	NULL
required	NULL
for	NULL
access	NULL
to	NULL
minimal	NULL
T-cell	NULL
receptor	NULL
a	NULL
@	NULL
-enhancer	NULL
chromatin	NULL
in	NULL
vivo	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:3223	NULL
.	NULL

Waltzer	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Bienz	NULL
.	NULL

1998	NULL
.	NULL

Drosophila	NULL
CBP	NULL
represses	NULL
the	NULL
transcription	NULL
factor	NULL
TCF	NULL
to	NULL
antagonize	NULL
wingless	NULL
signalling	NULL
.	NULL

Nature	NULL
395:521	NULL
.	NULL

Ishitani	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Ninomiya-Tsuji	NULL
,	NULL
S.	NULL
Nagai	NULL
,	NULL
M.	NULL
Nishita	NULL
,	NULL
M.	NULL
Meneghini	NULL
,	NULL
N.	NULL
Barker	NULL
,	NULL
M.	NULL
Waterman	NULL
,	NULL
B.	NULL
Bowerman	NULL
,	NULL
H.	NULL
Clevers	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
and	NULL
K.	NULL
Matsumoto	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
TAK1-NLK-MAPK-related	NULL
pathway	NULL
antagonizes	NULL
signalling	NULL
between	NULL
B-catenin	NULL
and	NULL
transcription	NULL
factor	NULL
TCF	NULL
.	NULL

Nature	NULL
399:798	NULL
.	NULL

Okamura	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
M.	NULL
Sigvardsson	NULL
,	NULL
J.	NULL
Galceran	NULL
,	NULL
S.	NULL
Verbeek	NULL
,	NULL
H.	NULL
Clevers	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1998	NULL
.	NULL

Redundant	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
differentiation	NULL
and	NULL
TCR	NULL
«	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
transcription	NULL
factors	NULL
LEF-1	NULL
and	NULL
TCF-1	NULL
.	NULL

Immunity	NULL
8:11	NULL
.	NULL

Kubo	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Nagasawa	NULL
,	NULL
H.	NULL
Nishimura	NULL
,	NULL
K.	NULL
Shigemoto	NULL
,	NULL
and	NULL
N.	NULL
Maruyama	NULL
.	NULL

1999	NULL
.	NULL

ATF-2	NULL
binding	NULL
regulatory	NULL
element	NULL
is	NULL
responsible	NULL
for	NULL
Ly49A	NULL
expression	NULL
in	NULL
murine	NULL
T	NULL
lymphoid	NULL
line	NULL
,	NULL
EL-4	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1444:191.	NULL
.	NULL

Fitzsimmons	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
Hagman	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
carly	NULL
stages	NULL
of	NULL
B-cell	NULL
and	NULL
T-cell	NULL
differentiation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:166	NULL
.	NULL

McQueen	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
B.	NULL
T.	NULL
Wilhelm	NULL
,	NULL
F.	NULL
Takei	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mager	NULL
.	NULL

2001	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
regions	NULL
of	NULL
the	NULL
closely	NULL
related	NULL
Ly-49c	NULL
and	NULL
j	NULL
genes	NULL
.	NULL

Immunogenetics	NULL
52:212	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

